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ABSTRACT OF DISSERTATION 
 
 
 
COOPERATIVE AND ANTAGONISTIC ROLES FOR HETEROCHROMATIN PROTEINS IN 
TRANSCRIPTIONAL REGULATION OF THE DROSOPHILA SEX DETERMINATION 
MASTERSWITCH GENE 
 
        HOAP was originally identified as a component of an ORC-containing multi-protein 
complex of Heterochromatin Protein 1 (HP1) from early Drosophila embryos. HOAP 
immunostaining showed prominent association of it with telomeres, and mutants for HOAP 
(cav1) showed it functions along with HP1 in forming a telomere capping complex that prevents 
telomeric fusions. 
 
        Weaker HOAP immunostaining is also observed in regions of pericentric heterochromatin 
and euchromatin. To examine the role of HOAP at these non-telomeric sites, we applied 
Affymetric Drosophila Genome Arrays to undertake a microarray expression profiling study of 
genes that are mis-expressed in cav1 mutant larvae. The data from four publicly available 
databases were used to assess the normal expression patterns of the affected genes. We found that 
the majority (67%) of genes with decreased expression levels in cav1 mutants (log2R< -2.0, pvalue≤ 
0.01) have normally testis-specific expression. These results could indicate a role of HOAP in 
testis-specific gene expression. Alternatively they could reflect reduced male viability due to the 
loss of HOAP, which resulted in the under-representation of males in the cav1 larval sample. The 
latter hypothesis is supported by the observation of 2.8-fold under-representation of males in cav1 
larvae when I used a yellow+-marked X chromosome to differentially mark male and female cav1 
larvae. Thus, this project is focused on determining and characterizing the cause of the reduced 
male viability. 
 
        Here I report a role for both HOAP and HP1 in regulating the establishment promoter, SxlPe, 
of the sex determination masterswitch, Sex lethal (Sxl). Female-specific activation of SxlPe is 
essential to females as it provides SXL protein to initiate productive female-specific splicing of 
the late Sxl transcripts which are transcribed in both sexes. We find inappropriate firing of SxlPe 
and splicing of Sxl transcripts in male cav mutants, whereas mutants for HP1 display Sxl splicing 
defects in both sexes. Both proteins are associated with SxlPe sequences. In embryos from HP1 
mothers and Sxl mutant fathers, female viability and RNA polymerase II recruitment to SxlPe is 
severely compromised. Our genetic and biochemical assays suggest a repressing activity for 
HOAP and both activating and repressing roles for HP1 at SxlPe. 
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Chapter One 
Background 
 
Euchromatin and heterochromatin 
 
Eukaryotic chromosomes are composed of DNA, which is wrapped around histones, and 
associated with a variety of non-histone proteins to form visible thread-like structures within each 
nucleus. The DNA/protein complexes, called chromatin, fall into two major classes: euchromatin 
and heterochromatin (Heitz, 1928).  Historically, this classification is based on their differential 
staining properties in the interphase nucleus and reflects different molecular compositions. 
Euchromatin is loosely packed and weakly staining during interphase, whereas heterochromatin 
remains tightly packed and deeply staining throughout the cell cycle (Heitz, 1928).  
Heterochromatin and euchromatin also have different functional properties.  Ris and Korenberg 
(Ris and Korenberg, 1979) showed that heterochromatin has low levels of transcription.  These 
low transcription levels may be related to its location next to the nuclear envelope, as Andrulis et 
al. (Andrulis et al., 1998) showed that reporter genes are silenced when targeted to the nuclear 
periphery.  The different properties of heterochromatin also include their DNA replication and 
recombination activities.  Lima-de-Faria and Jaworska (Lima-de-Faria and Jaworska, 1968) used 
tritiated thymidine ([3H]TdR) labeling to monitor chromosome replication patterns and concluded 
that heterochromatin is synthesized later in S phase than euchromatin.  Natarajan and Gropp 
(Natarajan and Gropp, 1971) showed the absence of chiasmata in homologously paired regions of 
heterochromatin during meiosis, possibly accounting for the minimal recombination observed in 
heterochromatin.  Yet heterochromatin was later shown to be required for homologous 
chromosome pairing and proper disjunction (Dernburg et al., 1996).  Cohesin proteins, which are 
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essential for proper chromosome segregation, are also dependent on Heterochromatin Protein 1 
(HP1) for their recruitment to peri-centric regions (Nonaka et al., 2002).  
The different functional properties of heterochromatin and euchromatin, described above, 
correlate with their distinct structures.  The more compact structure of heterochromatin, compared 
to euchromatin, is established and maintained through various epigenetic mechanisms which 
produce heritable changes in gene expression that do not involve mutations in the sequence of the 
gene itself (the Greek word “epi” means “over” or “above”).  These mechanisms involve non-
coding RNA molecules, histone modifications and, in some species, DNA methylation.  Covalent 
modifications on histone N-terminal tails (acetylation, methylation, phosphorylation etc.,) alter 
the chromatin structure by interacting with specific non-histone proteins to make chromatin more 
or less compact (Strahl and Allis, 2000).  Some of these histone modifications are responsible for 
recruiting heterochromatin specific non-histone proteins.  For example, SU(VAR)3-9 which is a 
histone H3 lysine 9-specific methyltransferase, converts monomethyl H3K9 into the dimethylated 
form, and dimethyl to trimethl H3K9, to provide binding-sites for HP1 at heterochromatic loci 
(James et al., 1989; Tschiersch et al., 1994).   
In the fission yeast Schizosaccharomyces pombe, the recruitment of the SU(VAR)3-9 homolog 
(Clr4) and Swi6 (HP1 homolog) to centromeric heterochromatin was shown to be mediated by 
the RNAi machinery (Volpe et al., 2002).  In Drosophila,  Elgin and co-workers showed that 
small RNAs, produced by the RNAi machinery from the most abundant transposable element 
1360, are required for HP1-dependent silencing of an adjacent reporter gene in pericentric 
heterochromatin (Haynes et al., 2006).  RNAi-independent mechanisms, involving DNA-binding 
proteins, were also shown to operate in the heterochromatin of centromeres and the mating type 
loci of S. pombe (Jia et al., 2004; Nakagawa et al., 2002).  HP1 recruitment to pericentric 
heterochromatin was proposed to occur through the DNA-binding activities of HOAP 
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(HP1/ORC-Associated Protein) and ORC (Origin Recognition Complex) proteins in Drosphila 
(Shareef et al., 2003).   
Heterochromatin can be further categorized into constitutive and facultative types.  Constitutive 
heterochromatin retains its heterochromatic properties in all cell types of a given species.  It is 
mainly found in pericentric and telomeric regions, which are enriched with transposons and non-
coding, repetitive DNA (Cooper, 1959; Goodfellow et al., 1985; Hannah, 1951).  K9-methylated 
histone H3 and HP1 are two conserved markers for constitutive heterochromatin.  Although it 
shares the compact features of constitutive heterochromatin, facultative heterochromatin (the latin 
word “facultas” means “opportunity”) has the opportunity to take on either the looser 
conformation of euchromatin or the more compact conformation of heterochromatin in specific 
cell types.  A gene contained within facultative heterochromatin in one cell type, where it is 
silenced, may be packaged into euchromatin and expressed in another cell type.  A classic 
example of facultative heterochromatin is the inactive X-chromosome in mammalian females 
(Chow and Brown, 2003), in which one of its two X chromosomes is randomly chosen to adopt a 
state of facultative heterochromatin and remain silent, while the other is packaged into 
euchromatin and capable of being expressed.  Facultative heterochromatin is marked by lysine 
27- methylated histone H3 (MeK27H3, which is recognized by the Polycomb protein (Fischle et 
al., 2003), the founding member of PcG repressor proteins, which shares the chromodomain 
homology with HP1.  The chromodomain allows chromodomain proteins to bind methylated 
histone H3, although with slightly different specificities (Nielsen et al., 2001). 
  
Position Effect Variegation (PEV) assay 
 
The classic epigenetic phenomenon, Position Effect Variegation (PEV), first described by Muller 
in 1930 (Muller, 1930), has been applied to identify non-histone chromosomal proteins which 
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affect euchromatic gene expression by altering chromosome structure.  PEV occurs when 
euchromatic genes are placed next to heterochromatin by a chromosomal rearrangement, causing 
the mosaic inactivation of these genes through random spreading of heterochromatin over them; 
once inactivated, the silent state is maintained during cell divisions to produce the variegated 
phenotype (Weiler and Wakimoto, 1995).  This position effect on the expression of euchromatic 
genes can be suppressed by dominant mutations in genes encoding trans-acting proteins involved 
in heterochromatin assembly.  This phenomenon prompted multiple genetic screens to identify a 
large number of Suppressor of variegation [Su(var)] genes encoding proteins that function in the 
assembly or maintenance of heterochromatin, including the Su(var)205 gene for the first 
identified heterochromatin protein, HP1, as well as the gene for the SU(VAR)3-9 enzyme 
responsible for lysine 9-specific methylation of histone H3 (James et al., 1989; Tschiersch et al., 
1994).  HP1 was first discovered in Drosophila and is a highly conserved heterochromatin 
component in species ranging from fission yeast to humans.  However, HP1 is also recruited to 
euchromatic regions (for example, cytological region 31 in Drosophila) and has been found to 
have a positive role in the expression of some genes in this region (Cryderman et al., 2005; 
Piacentini et al., 2003). 
 
Identification of HP1-ORC Associated Protein (HOAP) 
 
Because early studies failed to demonstrate DNA binding activity for HP1, its incorporation into 
heterochromatin was proposed to involve DNA-binding proteins.  A biochemical approach was 
used by previous members of the lab (Huang et al., 1998; Pak et al., 1997) to characterize HP1 
complexes from early Drosophila embryos in search of these proteins.  In these studies, HP1 was 
found to exist in three different protein complexes in the cytoplasm from early Drosophila 
embryos.  The smallest of these contained HP1 alone, whereas the two larger ones contained  
Origin Recognition Complex (ORC) subunits 2, 5 and 6 and hypo-phosphorylated HP1.  A novel 
5 
 
55-kDa protein was also observed in the Coomassie-stained profiles of the two larger complexes 
(Figure 1.1) and was subjected to Edman degradation to determine its identity.  Its peptide 
sequence matched the hypothetical protein-coding sequence of the anon fe 1G5 gene from 
Drosophila melanogaster, a gene that had been identified in a molecular screen for fast-evolving 
genes in Drosophila species (Schmid and Tautz, 1997).  Antibody raised against the protein 
product of the gene recognized p55 in the HP1 complexes and was found to co-
immunoprecipitate HP1 and ORC subunits in a reciprocal immunoprecipitation experiment 
(Huang et al., 1998; Shareef et al., 2003). The anon fe 1G5 gene product, therefore, was renamed 
HP1/ORC-Associated Protein (HOAP).  The N-terminus of HOAP contains sequence similarity 
to the HMG box DNA binding motif of the mammalian Sex-determining Region of the Y (SRY) 
proteins (24% identity and 40% similarity), and a recombinant HOAP protein was shown to bind 
specific Drosophila satellite and a Drosophila telomere-associated sequence (TAS) in vitro 
(Shareef et al., 2001).  
 
The DNA-binding activities of HOAP and ORC led the lab to propose a role for them in targeting 
HP1 to heterochromatin (Shareef et al., 2001).  Supporting this model, mutants for ORC2 
exhibited reduced HP1 immunostaining in pericentric heterochromatin of diploid nuclei, and 
mutations in either ORC2 or HOAP suppress PEV (Huang et al., 1998).  HOAP immunostaining 
showed prominent association of it with telomeres; weaker immunostaining was also observed in 
regions of pericentric heterochromatin and euchromatin (Figure 1.2).  The partial overlap between 
the immunostaining patterns for HOAP and HP1 suggested a more specialized function for 
HOAP in heterochromatin, perhaps in targeting HP1 to heterochromatin nucleation sites.  The C-
terminus of HOAP contains three novel PETEMNE peptide motifs (Figure 1.1), which were 
shown to be responsible for binding HP1 through HP1 chromo shadow domain and hinge domain 
(Badugu et al., 2003; Badugu et al., 2005).  Interestingly, incubation of salivary glands with 
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PETEMNE peptide or di-MeK9H3 peptide causes release of HP1 from pericentric 
heterochromatin (Badugu et al., 2003).  
 
HOAP at telomeres  
 
The ends of linear eukaryotic chromosomes, called telomeres (the Greek word “telos” means 
“end”, and “mere” means “part”), have a heterochromatic structure which protects chromosomes 
from undergoing end-to-end fusion or degradation.  Telomeres of most eukaryotes are composed 
of tandem repeats of short sequences (e.g. TTAGGG repeats), which are generated by an RNA-
templated DNA polymerase enzyme called telomerase (Greider and Blackburn, 1985).  The 
extreme end of telomeres is protected by its surrounding proteins to be distinguished by cells 
from broken ends.  In most human cells, this includes the POT1 (protection of telomere 1) 
polypeptide that binds to 3’-overhang (Baumann and Cech, 2001; Baumann et al., 2002), TRF1 
and TRF2 (telomeric repeat binding factor 1 and 2) proteins that directly bind to TTAGGG 
duplex  (Broccoli et al., 1997; van Steensel et al., 1998) and TRF2-interacting Ku70/80 proteins 
that are also essential for DNA repair (Song et al., 2000).   
 
Drosophila does not have a gene for telomerase.  Rather, the RNA-templated DNA polymerase 
activity of a reverse transcriptase (RT) is encoded in the telomeric DNA itself (Pardue et al., 
1996), which consists of an array of non-long-terminal-repeat (non-LTR) retrotransposons (Het-
A, TART and TAHRE).  TART and TAHRE elements contain RT-coding sequence (Abad et al., 
2004; Mason and Biessmann, 1995; Pardue et al., 1996).  In Drosophila, HP1 and HOAP form a 
telomere-capping complex to protect telomeres (Cenci et al., 2003).  Loss-of-function mutations 
in the HOAP-encoding gene caravaggio (cav) were identified on the basis of their telomere-
telomere fusion phenotype (Cenci et al., 2003).  Mutants for HP1 had been shown earlier to have 
a telomere fusion phenotype (Fanti et al., 1998).  The cav1 mutant identified in the Cenci et al. 
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study (Cenci et al., 2003) expresses a HOAP protein that lacks the third HP1-interacting 
PETEMNE motif in its C-terminus.  Mitotic chromosomes in larval brains from this cav1 mutant 
lack HOAP immunostaining at telomeres.  The HP1 telomeric signals were unable to be analyzed 
in mitotic chromosomes from cav1 mutants, due to dispersion of HP1 from chromosomes during 
mitosis (Kellum et al., 1995).  However, both HOAP and HP1 signals were lost at telomeres of 
polytene chromosomes from the cav1 mutant, in spite of the fact that polytene chromosomes do 
not undergo telomeric fusions (unpublished data).  The HOAP signals were still present in a 
minor fraction of mitotic chromosomes in Su(var)205 mutants that displayed telomere fusions, 
indicating that HOAP can bind to telomeres in an HP1-independent manner.  Cenci et al. (Cenci 
et al., 2003) also showed that HOAP can bind telomeres lacking all telomere-associated 
sequences.  A recently discovered HipHop protein interacts with HP1/HOAP telomere capping 
complex, and its binding to telomeres is also independent of specific telomeric sequences (Gao et 
al., 2010).  Binding of both HOAP and HP1 to telomeres is dependent upon a telomere 
maintenance mechanism mediated by the ATM (ataxia telangiectasia mutated) and ATR (ATM 
and Rad3-related) checkpoint kinases, presumably by processing the DNA to provide a specific 
secondary structural feature needed for HOAP/HP1 binding (Bi et al., 2005).  The transcription 
factor WOC is also required for telomere-capping through a mechanism that does not involve 
either HOAP, HP1, or ATM/ATR (Raffa et al., 2005). 
 
HP1 has a second function at telomeres in repressing the transcription of telomeric transposons 
through its association with MeK9H3.  Recruitment of MeK9H3 to telomeres does not involve 
the RNAi machinery in the soma, but does involve it in the germline (Perrini et al., 2004; 
Savitsky, 2006; Shpiz et al., 2007).  ORC also does not appear to be enriched in telomeres or 
required to prevent telomere fusions (Cenci et al., 2003).    
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HOAP in 3L pericentric heterochromatin 
 
A previous member of the Kellum lab (Rama Badugu, unpublished data) used a direct approach, 
chromatin immunoprecipitation (ChIP) on chip experiments, to identify HOAP-binding DNA 
sequences in a region of 3L heterochromatin where HOAP immunostaining was consistently 
observed (Figure 1.2) (Shareef et al., 2001).  For this study, a custom microarray containing 45bp 
oligonucleotides spanning 525kb of non-repetitive DNA from this region was made. The results 
of this study are shown in Figure 1.3.  HOAP was found to be enriched at least two fold in the 
ChIP sample relative to the input sample at nine sites within this region.  Four of these sites were 
associated with regions flanking transposable elements (blue stars) and five were associated with 
regions flanking unique gene coding sequences (red stars).  Among twenty three genes included 
in this genomic region, only five were associated with HOAP and four of these were testis-
specific (CG11226, CG32462, CG32459, and CG32461, shown in red letters), as assessed 
through cDNA representation data and microarray expression profiling data (Chintapalli et al., 
2007; Parisi et al., 2004).  The fifth gene, CG11131, is expressed specifically in the male 
accessory gonad.    
 
HOAP in euchromatin 
 
Weaker HOAP immunostaining is also observed at numerous sites distributed throughout the 
euchromatic arms of polytene chromosomes (Figure 1.2).  Affymetrix Drosophila Genome 
microarrays were used by Momin Shareef in an expression profiling study to identify genes that 
are mis-regulated in the cav1 mutant, as candidate HOAP-regulated genes, before I joined the lab. 
The expression profile of the cav1 mutant was compared to that of wild type animals at the first 
and second instar larval stage, prior to the lethal phase for the cav1 mutant (Cenci et al., 2003).  
Out of 13,500 transcription units represented on this array, 183 genes were found to have 
significantly altered expression (log2R> +2.0 or log2R< -2.0, p< 0.01) in cav1 mutant larvae. 
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Within this set, 142 genes had decreased transcript levels and 41 genes had increased levels in the 
cav1 mutant (Table 1.1).  
 
We used four publicly available databases to catalogue the normal expression profiles of genes in 
each data set.  A gene’s relative representation in publicly available tissue-specific cDNA 
libraries (Andrews et al., 2000; Stapleton et al., 2002) provided the first method for assessing its 
normal expression. This analysis was complemented by data from other published microarray 
profiling studies of sex- or tissue-specific gene expression in Drosophila melanogaster 
(Arbeitman et al., 2002; Chintapalli et al., 2007; Parisi et al., 2004).  Six groups were used to 
categorize the genes with decreased transcript levels in the cav1 mutant (Multiple, Rare, Embryo, 
Ovary, Testis and Testis & Ovary), as summarized in Table 1.1.  Four groups were used to 
classify the genes with increased transcript levels (Carcass, Midgut, Multiple and Rare).  Genes 
categorized as “Multiple” were represented in cDNA libraries of multiple developmental 
specificities and expressed at high levels in multiple adult tissues (Chintapalli et al., 2007).  
Genes categorized as “Rare” were represented by a single of few cDNA clones, usually one 
generated from a mixed pools of RNA of various developmental specificities, and were detected 
at low levels in all or multiple tissues. Those categorized as specific for a given tissue (e.g. testis) 
were predominantly or only represented in cDNA libraries of that specificity and were enriched 
specifically in that tissue in the tissue-specific expression profiling studies of Chintapalli et al. 
and Parisi et al. (Chintapalli et al., 2007; Parisi et al., 2004).  The most striking pattern to emerge 
from these analyses was the abundance of testis-specific genes (67%) in the set of genes with 
decreased transcript levels in cav1 mutant.  This is in contrast to only 12% of Drosophila 
melanogaster genes normally being testis-specific  (Boutanaev et al., 2002; Parisi et al., 2004).  
No testis-enriched genes were found in the set of genes with increased transcript levels in the cav1 
mutant.  
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The results of the cav1 expression profiling study could be interpreted in three possible ways. The 
direct interpretation is that HOAP is required for expression of these testis-specific genes. An 
alternative interpretation is that HOAP is required for male viability, and the decreased level of 
testis-specific transcripts in the cav1 mutant results from under-representation of males in the 
larvae used to extract RNA.  The last interpretation is that HOAP is required for both: for 
expression of testis-specific genes and for some male-specific genes needed for male viability.  
The second possibility was supported by several studies showing males are more sensitive to loss 
of heterochromatin proteins (Liu et al., 2005; Spierer et al., 2005).  Sun and co-workers, (Liu et 
al., 2005; Spierer et al., 2005) used the UAS/GAL4 binary system to drive the expression of a 
UAS-driven transgene for HP1 interference RNA to knock down HP1 levels and observed 
enhanced lethality for adult males. A similar phenotype was also observed for mutants for the 
HP1-interacting proteins, SU(VAR)3-7 (Spierer et al., 2005) and Drosophila TIF1β (bonus) 
(Beckstead et al., 2005).  Because of these findings, the first goal of my project was to determine 
whether mutants for HOAP have reduced male viability, and if so, to characterize the cause of 
this reduced viability. 
 
 
 
 
 
  
 
 
 
 
Copyright © Hui Li 2011 
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Figure 1.1.  HOAP (HP1/ORC-Associated Protein) was identified as a 55 kDa polypeptide in 
the medium and large HP1 complex from early Drosophila embryos.  A) Coomassie-staining 
of polypeptides eluted from a control IgG (lanes 1, 3, and 5) anti-HP1 immunoaffinity (lanes 2, 4, 
and 6) column loaded with gel filtration fractions containing the small  (lanes 1 and 2), medium 
(lanes 3 and 4) and large (lanes 5 and 6) HP1 complexes, respectively (Huang et al., 1998; 
Shareef et al., 2003).  Positions of molecular weight markers shown on left and polypeptides with 
molecular weights for HP1 (HP1), ORC subunits 2 and 6 (ORC2 and ORC6), and unknown 
polypeptides  (p55, p40, and p35) on the right. B) Molecular structure of HOAP showing N-
terminal region of similarity to the HMG box DNA binding motif (slashed lines) and three novel 
PETEMNE repeats responsible for HP1 binding in the C-terminus (horizontal lines) (Badugu et 
al., 2003) 
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Figure 1.2.  HOAP and HP1 have partially overlapping distributions on polytene 
chromosomes from larval salivary glands.  A) HOAP immunostaining shows prominent 
association of it with telomeres (short arrows).  Weaker immunostaining is also observed in 
regions of pericentric heterochromatin (long arrows) and euchromatin (stars) (Badugu et al., 
2003).  B) HP1 immunostaining shows pronounced enrichment throughout the chromocenter 
(long arrows) and at telomeres (short arrows).  Weaker signals were also observed at many 
euchromatic sites (stars) (Shareef et al., 2003) 
B) 
A) 
 
B 
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Figure 1.3.  HOAP/HP1 ChIP on chip analysis of region of 3L heterochromatin.  The 
log2Ratio (Y axis) for enrichment of a sequence in the HOAP- (red solid line) or HP- (green 
dashed line) ChIP fraction relative to the input (normalized against a set of euchromatic gene 
standards) is plotted along the X-axis showing the Drosophila genome assembly coordinates 
(GBrowse) (Tweedie et al., 2009).  Red stars indicate enrichment associated with flanking testis-
specific genes. Blue stars indicate enrichment associated with flanking transposable elements. 
 
 
14 
 
Table 1.1.  Summary of the results of cav1 expression profiling study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tissue # Genes Fraction  Tissue # Genes Fraction 
       
Testis     95 67.0%  Multiple    24    58.5% 
Multiple     34 23.9%  Rare      8    19.5% 
Rare       4   2.8%  Midgut      8    19.5% 
Testis & Ovary       4   2.8%  Carcass      1     2.5% 
Ovary       4   2.8%     
Embryo       1   0.7%     
Total  142 100%  Total    41    100% 
 
Genes with A) reduced or B) elevated transcript levels were characterized according to their 
expression profiles in wild type animals using a combination of previously published cDNA 
representation (Andrews et al., 2000; Stapleton et al., 2002) and microarray expression 
profiling data (Arbeitman et al., 2002; Chintapalli et al., 2007; Parisi et al., 2004).   
 
 
Embryo
Multiple
Ovary
Rare
Testis
Testis & 
Ovary
MultipleRare
Carcass
Midgut
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Chapter Two 
HOAP is required for Male Viability 
 
RT-PCR assays of a select group of euchromatic genes from the cav expression profiling 
study 
 
Before beginning the experiments to determine the nature of the effect of the cav1 mutation on 
testis-specific transcripts, I applied semi-quantitative RT-PCR assays to determine the validity of 
the microarray findings.  Genes with either testis-specific or testis-non-specific normal expression 
patterns (Figure 2.1), five with decreased transcript levels (left) and three with increased 
transcript levels (right), were selected for the analysis.  The Drosophila RpA-70 gene, which was 
unaffected in the expression profiling study, was used as the normalizing standard.  Figure 2.1B 
shows the results of these assays to be consistent with the results of the microarray study.  
Because HOAP interacts with HP1 and RNAi knockdown of the gene for HP1 [Su(var)205] also 
causes enhanced male lethality (Liu et al., 2005), I also examined the transcript levels for these 
genes in Su(var)205 mutants. The results were similar to those of RNA from the cav1 mutant, 
which may indicate a shared role for the two proteins in regulating this class of genes.  
Alternatively, these genes may be similarly indirectly affected in both mutants, as a result of the 
requirement for both for male viability. 
 
Ratio of sex-non-specific to female-specific tra transcripts is altered in cav1 mutant  
 
As discussed earlier, the reduced testis-specific transcript levels could reflect under-
representation of males in the cav1 mutant larvae.  To determine whether somatic sex-specific 
transcripts are also reduced in the cav1 mutant, I used RT-PCR assays to measure the ratio of the 
sex-non-specific- to female-spliced forms of the sex differentiation gene in the soma, transformer 
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(tra), in RNA from the cav1 mutant.  The tra gene is regulated by the SXL protein to undergo 
alternative splicing to produce a female-specific transcript in females in addition to a non-sex-
specific transcript in both sexes (Boggs et al., 1987).  The non-sex-specific transcript is not 
protein coding.  In females only, tra pre-mRNA splicing is repressed by SXL protein to produce a 
protein-coding mRNA.  The results of semi-quantitative RT-PCR experiments showed that the 
ratio of the non-sex-specific tra transcript to the female-specific one in the RNA sample from 
cav1 mutant larvae is reduced by 6-8 folds relative to that in wild type animals (Figure 2.2).  
Similar results were obtained for larvae that were mutant for HP1 (Su(var)2055/Su(var)20504).  
The over-representation of the female-specific tra transcript in the Su(var)205 mutants is 
consistent with the reduced male viability observed in animals with reduced HP1 levels through 
RNAi knock-down (Liu et al., 2005).  The similar reduction in the female-specific transcript in 
mutants for HOAP may indicate that males are similarly under-represented in it. 
 
Males are under-represented in cav1 mutant larvae 
 
To more directly determine the ratio of males to females in the cav1 mutant at the larval stage, 
larval gonad morphology was used to sex them. The larval gonads of both sexes appear as small 
transparent circular regions, surrounded by fat tissues, but male gonads are considerably larger 
and can be used as means to sex larvae.  I found none of the cav1 mutant larvae to contain gonads 
of the size expected for males.  However, this result could also reflect a defect in male gonad 
development in the cav1 mutant, or a mitotic defect in stem cells of the gonad.  I, therefore, used 
an X-linked genetic marker (y+) for larval mouth hook color as an alternative method to 
determine the sex of larvae that does not depend on proper gonad development.  To this end, cav1 
fathers carrying the wild type y+ allele on their single X chromosome were crossed to cav1 
mothers carrying a y- allele on both X chromosomes.  All male progeny from this cross would 
carry the y- allele and have brown mouth hooks, and thus, they could be differentiated from all 
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female progeny carrying y+ and having black mouth hooks.   The results indicated a 2.8-fold 
under-representation of male larvae in the cav1 homozygous mutant (P < 0.01) (Table 2.1).  A 
smaller, but insignificant (P > 0.05), under-representation of males was observed in the cav1 
heterozygous larvae.  Interestingly, male gonad size seemed to be reduced in the surviving cav1 
mutant male larvae.  This reduced size could reflect a sex transformation of male gonad or a 
mitotic defect in stem cells of the gonad, as well as a requirement for HOAP for survival of males 
to the larval stage.  No sex-specific viability defect was observed in cav1 heterozygous animals at 
adult stage.    
 
Ubiquitous reduction of cav transcripts through interference RNA expression reduces adult 
male viability 
 
Liu et al. (2005) (Liu et al., 2005) used the GAL4/UAS binary system to drive the ubiquitous 
expression of a UAS- transgene for interference RNA against Su(var)205 and showed that male 
viability is preferentially reduced when Su(var)205 transcript levels are reduced to between 60-
90% of wild type levels.  The GAL4/UAS system  (Duffy, 2002) consists of two parts: the Gal4 
gene encoding a yeast transcription activator, placed under the control of a Drosophila tissue 
specific promoter, is used to drive the expression of a target gene controlled by a UAS sequence 
(Upstream Activation Sequence) to which GAL4 protein specifically binds to activate 
transcription.   
 
To determine if partial HOAP knockdown would similarly preferentially affect male viability, I 
used the GAL4/UAS binary system to express a pUAST transgene for cav interference RNA (cav 
RNAi), which had been made by a former member of the lab (Youngdong Yoo).  I used the 
Act5C-GAL4 driver which is expressed ubiquitously throughout the animal’s life span to drive 
expression of cav interference RNA (UAS-cav-RNAi).  Reciprocal crosses were used in the 
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assays. Expression of cav RNAi from two transgenic lines, F8 and #543, through a maternally-
contributed Act5C-GAL4 driver, resulted in a 2.5-fold and 1.5-fold reduction in the viability of 
adult males relative to females, respectively (Table 2.2). A third cav RNAi transgenic line, #662, 
showed a complete lethality of both males and females when driven by the same GAL4 driver 
(Table 2.2).  The reciprocal cross, in which the Act5C-GAL4 driver was paternally contributed, 
was done in order to determine the requirement for early expression of GAL4 protein in reducing 
male viability.  The results showed that the male viability was reduced by 1.4 fold in this cross, 
lower than 2.5-fold reduction observed when the Act5C-GAL4 driver was contributed by the 
mother.  While maternal expression of GAL4 protein was not sufficient to reduce viability of 
male progeny lacking the GAL4 transgene, the stronger effect on male viability in this cross 
suggests a requirement for early knockdown of cav in producing the maximum effect. 
 
I used semi-quantitative RT-PCR assays of RNA extracted from larvae carrying both transgenes 
(Act5C-GAL4/UAS-cav-RNAi), identified through their lack of the GFP marker on the 
homologous balancer chromosome.  The results (Figure 2.4) showed the severity of the effect on 
male viability in different transgenic lines correlates with the degree to which endogenous cav 
mRNA is reduced in each.  The endogenous cav mRNA levels are decreased by at least 100 fold 
in line #662, which resulted in a complete lethal phenotype for both sexes, in comparison to the 
~5- fold reduction in line F8, which caused 2.5-fold reduction in male viability.  The results are 
consistent with partial knockdown of HOAP causing preferential male lethality and complete loss 
of HOAP causing lethality of both sexes, similar to what was observed with RNAi knockdown of 
HP1 (Liu et al., 2005). 
 
I also crossed female and male adults carrying both the Act5C-GAL4 driver and UAS-cav-RNAi 
transgene to wild type animals and examined the ratio of male to female in their progeny.  The 
results, as displayed in Table 2.3, showed that there is no significant sex-specific effect on 
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viability of progeny in either cross.  This result could indicate that HOAP is not required either 
paternally or maternally for male viability. Alternatively, the heat shock promoter of the pUAST 
vector used in these experiments is now known to express poorly in germline cells, and therefore, 
may not have provided sufficient expression of cav RNAi to produce parental effects.   
 
Male viability is reduced in heterozygotes for a newly recovered cav allele  
 
Finally, a dominant reduced male viability phenotype  was observed in a newly recovered cav 
allele (cav2248) which contains a G>A transition at nucleotide 111 of the HOAP coding sequence 
resulting in a nonsense codon at amino acid 37 of the 377 amino-acid HOAP-coding sequence.    
This cav2248 allele apparently behaves as a dominant negative allele, as its effect on male viability 
is comparable to that caused by a ~5-fold reduction of HOAP by cav RNAi knockdown but 
stronger than a 2-fold reduction caused by a deletion that removes the chromosome interval 
containing the cav gene [Df(3R)crb-F89-4] in heterozygous condition.  Adult male viability is 
reduced by 1.8-fold in animals carrying the cav2248 allele in heterozygous condition (Table 2.4).  
The cav2248 allele also caused smaller, but significant, reduction in viability of male progeny that 
was observed when heterozygous males for it were crossed to wild type mothers.  Furthermore, 
the paternal mutation also affected the viability of male progeny lacking the mutation and had an 
effect that was almost as dramatic as that when the mutation was present in both parents (Table 
2.4).  
 
This cav2248 allele is associated with embryonic lethality in both heterozygotes and homozygotes 
for it.  No non-Tb larvae were observed from cav2248/TM6Tb crossed to itself or to cav1/TM6Tb.  
Embryos that were heterozygous for the allele were identified through their moderate level of 
GFP expression from the GFP-marked balancer chromosome (twi-GAL4, UAS-GFP marked 
balancer) and were observed to arrest development late in embryogenesis at a time when denticle 
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belts have become barely visible (arrows in Figure 2.4A).  Homozygotes for cav2248 had an earlier 
lethal phase before denticle belts were visible (Figure 2.4A) that was associated with a high 
frequency of telomeric defects as observed through DAPI-staining (Figure 2.4B) .  Telomeric 
fusions were not observed at increased frequency in cav2248 heterozygous males. 
 
Discussion 
 
HOAP is a novel HP1-interacting protein which is associated with telomeres, pericentric 
heterochromatin and many euchromatic sites.  Consistent with its strong telomeric staining, 
HOAP has been shown to protect telomeres from end-to-end fusions.  In order to study its non-
telomeric functions, a microarray experiment was applied and the results showed the majority of 
genes with decreased transcript levels are testis-specific. This result could either indicate a role of 
HOAP in regulating testis-specific gene expression or a requirement for it for male viability, 
resulting in under-representation of males in cav1 mutant larvae.   
 
I used genetic assays to show that HOAP is, indeed, required for male viability.  Reduced male 
viability was observed in cav2248 heterozygotes, cav1 homozygotes, and animals expressing cav 
interference RNA.  The viability of male progeny from the cross between males carrying Act5C-
GAL4 and females carrying UAS-cav-RNAiF8 was significantly reduced 1.4-fold (p < 0.05), but 
the more pronounced reduction (2.5-fold, p < 0.01) in the reciprocal cross indicated a need for 
early knockdown through pre-loading of the embryos with maternal GAL4 protein.   
 
The requirement of HOAP for male viability does not appear to be strongly dependent upon its 
telomeric function.  Telomere fusions were not observed more frequently in males than females 
of cav1 mutant larvae (Yikang Rong, personal communication), and they were not observed at 
high frequency in cav2248 heterozygous males that die as late staged embryos.  It should be noted 
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that HOAP may also function directly or indirectly in male gonad development, as evidenced by 
the reduced size of the larval gonad in cav1 mutant males.   
 
To elucidate the cause and mechanism of this reduced male viability, which presumably reflects a 
function for HOAP at non-telomeric sites, the following three hypotheses will be tested:  
 
A) The heterochromatic Y chromosome in males exacerbates the lethality associated with 
the telomeric defects in mutants for HOAP, by more rapidly depleting HOAP from 
telomeres. 
B) A defect in the sex determination pathway that prevents dosage compensation from 
properly occurring in males.  This defect could occur early in the decision of whether to 
activate dosage compensation in males or in the process of dosage compensation itself.  
C) A defect in gene expression required for male viability. 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Hui Li 2011 
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Figure 2.1.  Results of cav1 microarray study were corroborated by RT-PCR assays. 
A) Genes selected for RT-PCR assays, include five with decreased transcript levels (left) and 
three with increased transcript levels in cav1 mutant larvae (right).  B) RT-PCR assays of genes 
with decreased transcript levels (left) and increased transcript levels (right) in a ten-fold dilution 
series of RNA from wt, Su(var)2055/Su(var)20504 and cav1 larvae are shown.  RpA-70 was used 
as the normalizing standard.  The identity of PCR product of unexpected size for CG4669 
transcript (indicated by >) is unknown.   
 
 
 
 
Genes with decreased expression in cav1 
microarray 
Genes with increased expression in cav1 
microarray 
Gene 
name 
Log2R P 
value 
Expression 
Pattern 
Gene 
name 
Log2R P 
value 
Expression 
Pattern 
CG2127 -4.72 0.005 testis CG5778 19.63 0.037 Multiple 
CG8701 -7.77 0.032 testis CG1304 4.08 0.036 Multiple 
CG4669 -5.29 0.006 testis CG2071 6.44 0.016 Multiple 
CG16741 -7.06 0.017 testis     
CG8914 -9.27 0.002 testis     
A) 
B) 
> > 
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Figure 2.2.  Female-specific tra transcript is increased 6 to 8-fold in cav1 and Su(var)205 
mutant larvae relative to wild type.  A) Primer pairs P1 and P2 used to detect sex non-
specific and female tra transcripts in B) RT-PCR assays of a ten-fold dilution series of RNA 
extracted from wild type, Su(var)2055/Su(var)2054 and cav1 larvae are shown.  The size of the 
products expected from the sex non-specific and female-specific tra transcripts are indicated.  
* indicates a product of unexpected size of unknown identity.   
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Figure 2.3.  Endogenous cav RNA level was reduced in transgenic animals expressing cav 
interference RNA.  RT-PCR assays using a ten-fold dilution series for RNA templates from wt 
and UAS-cav-RNAi/Act5C-GAL4 larvae are shown.  The cav mRNA level was reduced by 10-
fold in line F8 which results in reduced male viability and by 100-fold in line #662 which reduces 
viability of both sexes (right) in comparison to RpA-70 normalizing standard (left). 
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Figure 2.4.  Homozygotes and male heterozygotes for the cav2248 allele arrest development 
during embryogenesis .  A) Cuticle preparations of cav2248 homozygous and heterozygous 
embryos that fail to progress to the larval stage show that heterozygotes (the majority of which 
are males) die late in embryogenesis when denticle belts are barely visible (short arrows), 
whereas homozygotes die earlier in embryogenesis before denticle belt formation.  B) DAPI 
nuclear staining shows the early lethality for cav2248 homozygous embryos to be associated with 
telomeric end-to-end fusions (short arrows), whereas few defects were observed in heterozygous 
embryos arrested later in development. 
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Table 2.1.  Males were under-represented in cav1 homozygous larvae.   
 
 
A) Using the dominant y+ genetic marker required for pigmentation of larval mouth hooks to sex 
individual larvae and the dominant Tubby (Tb) marker on the TM6 balancer chromosome for 
Chromosome 3 to identify homogyzous and heterozygous cav1 larvae, a significant reduction in 
the number of male vs. female larvae, relative to their heterozygous siblings (n>161, Z=5.2, p < 
0.01), was observed.  B) No effect on male viability was observed in cav1 heterozygous adults.  
TM3 is a balancer chromosome for Chromosome 3 that carries a dominant Stubble (Sb) marker, 
which is visible in adults.    
 
 
 
 
 
 
 
 
 
A) 
♀y-/ y-; cav1/TM6Tb   X   ♂y+/ Y; cav1/TM6Tb 
Larvae Progeny Phenotype Number ♀ : ♂ 
cav1/ cav1 y+  ♀ 119 2.83 : 1 *** 
 y-  ♂ 42  
cav1/TM6Tb y+  ♀ 130 1.11 : 1 
 y-  ♂ 117  
 
B) 
♀ cav1/TM3Sb   X   ♂ cav1/TM3Sb 
Adult Progeny sex Number ♀ : ♂ 
cav1/TM3Sb  ♀ 186 1.08 : 1 
 ♂ 172  
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Table 2.2.  Enhanced male lethality was observed in animals expressing cav interference 
RNA.   
 
A) Significant reduction in male viability was observed in multiple UAS-cav-RNAi transgenic 
lines driven by the ubiquitous Act5C-GAL4 driver in mothers, in comparison to their siblings 
carrying either transgene alone (***1: n>852, Z = 7.8, p < 0.01;  ***2: n>295, Z = 3.7, p < 0.01).  
B) Male viability was reduced less, but also significantly, in the reciprocal cross in which the 
Act5C-GAL4 driver was contributed by their fathers (**: n>882, Z = 3.0, p < 0.05). 
 
 
 
 
 
 
A) 
♀ Act5C-GAL4/CyO   X   ♂ UAS-cav-RNAi/CyO 
 #543 F8 #662 
Adult Progeny  Total  ♀ : ♂  Total  ♀ : ♂  Total  ♀ : ♂  
UAS-cav-RNAi/ 
Act5C-GAL4  
♀ 179 1.54:1***1 608  2.49: 1***2 0 0 : 0 
 ♂ 116  244   0  
UAS-cav-RNAi/CyO  ♀ 112 0.85 : 1 622  1.03 : 1 134 0.94 : 1 
 ♂ 131  606   143  
Act5C-GAL4/CyO  ♀ 108 0.89 : 1 579  1.03 : 1 121 1.20 : 1 
  ♂ 121  564   101  
 
B) 
♀  UAS-cav-RNAiF8/CyO   X   ♂  Act5C-GAL4/CyO 
Adult Progeny   Total  ♀ : ♂  
UAS-cav-RNAi/Act5C-GAL4  ♀ 516  1.41 : 1** 
 ♂ 366   
UAS-cav-RNAi/CyO  ♀ 528  0.99 : 1 
 ♂ 531   
Act5C-GAL4/CyO  ♀ 518  1.22 : 1 
 ♂ 423   
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Table 2.3.  Sex-specific viability was not affected in progeny from crosses between animals 
carrying both the Act5C-GAL4 and UAS-cav-RNAiF8 in either parent crossed to wild type.   
 
A) No sex-specific lethality was observed in progeny from the cross between Act5C-GAL4/ 
UAS-cav-RNAiF8 mothers and wt fathers.  B) Male viability was insignificantly reduced in 
progeny from the cross between Act5C-GAL4/ UAS-cav-RNAiF8 fathers and wt mothers against 
hypothetical 1:1 (*: n>558, Z = 1.2, p > 0.10).   
 
 
 
 
 
 
 
 
 
 
A) 
♀ Act5C-GAL4/ UAS-cav-RNAiF8   X   ♂ wt 
Adult Progeny  Sex Total ♀ : ♂ 
UAS-cav-RNAiF8/+ ♀ 223 1.07 : 1 
  ♂ 209  
 Act5C-GAL4/+  ♀ 225 1.01 : 1 
 ♂ 222  
 
B) 
♀  wt X   ♂ Act5C-GAL4/ UAS-cav-RNAi F8 
Adult Progeny  Sex Total ♀ : ♂ 
UAS-cav-RNAiF8/+ ♀ 260 0.87 : 1 
  ♂ 298  
 Act5C-GAL4/+  ♀ 256 0.88 : 1 
 ♂ 291  
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Table 2.4.  Dominant reduced male viability was observed in progeny from animals that 
were heterozygous for the cav2248 allele.   
 
A) A strong and significant reduction in male viability was observed in progeny from parents that 
both had a cav2248/TM3Sb genotype against hypothetical 1:1 (n>274, Z=2.9, p < 0.05).  B) A 
smaller but statistically insignificant reduction in male viability was observed in progeny from 
cav2248 heterozygous mothers crossed to wild type (n>285, Z=1.5, p > 0.05).  B) A significant 
reduction in male viability was observed when both classes of progeny from fathers carrying 
cav2248 allele in heterozygous condition, against hypothetical 1:1 (n>274, Z=2.9, p > 0.05). 
 
 
 
 
 
A) 
♀ cav2248/TM3Sb   X   ♂ cav2248/TM3Sb 
Adult Progeny Sex Number ♀ : ♂ 
cav2248/ TM3Sb ♀ 202 1.84 : 1 ** 
 ♂ 110  
 
B) 
♀ cav2248/TM3Sb   X   ♂ +/+ 
Adult Progeny Sex Number ♀ : ♂ 
cav2248/ + ♀ 161 1.30 : 1  
 ♂ 124  
TM3/+ ♀ 107 0.98 : 1  
 ♂ 109  
 
C) 
♀ +/+  X   ♂ cav2248/TM3Sb 
Adult Progeny Sex Number ♀ : ♂ 
cav2248/ + ♀ 195 1.70 : 1**  
 ♂ 115  
TM3/+ ♀ 170 1.63 : 1  
 ♂ 104  
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Chapter Three 
The Role of the Y Chromosome in Male Lethality 
 
Introduction 
 
In order to test the hypothesis that the heterochromatic Y chromosome in males exacerbates the 
effect of reducing HOAP by titrating away heterochromatin proteins and more rapidly depleting 
it, I introduced a Y chromosome into females and an extra Y chromosome into males expressing 
cav interference RNA.  The Y chromosome is not required for Drosophila male viability or 
sexual differentiation.  However, because it is almost entirely composed of heterochromatin and 
has numerous binding sites for heterochromatin proteins, it can suppress positive effect 
variegation (Spofford, 1976).  It is, therefore, possible that it could titrate out heterochromatin 
proteins to make males more vulnerable to reduced levels of HOAP and, therefore, more 
susceptible to telomeric fusions.  In fact, the male-specific lethality of mutants for bonus, the 
TIF1β HP1-interacting protein, which acts as a suppressor of variegation, was shown to require 
the presence of a Y chromosome (Beckstead et al., 2005).  Beckstead et al. (2005) showed that a 
loss-of-function allele of bonus (bon434) caused an almost complete male lethality under 
homozygous condition.  This male lethality was rescued when C(1:Y); bon43/TM6 males were 
crossed to bon43/TM6 females to generate male bon434/ bon434 lacking a Y chromosome (XO).  
Interestingly, the bon434/ bon434 females, also generated from this cross, which carry a Y 
chromosome (XXY), exhibited 100% lethality.  Similar effects on sex-specific viability were also 
observed with introduction of extra heterochromatin derived from the X chromosome.  I, 
therefore, used a similar approach to test the role of the Y chromosome in the HOAP-dependent 
male viability phenotype.   
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Results 
 
To test whether the reduced male viability in animals containing reduced HOAP is similarly due 
to the titrating effect of the Y chromosome, the C(1;Y) chromosome, formed by a rearrangement 
that fuses an X and Y chromosome, was introduced into both males and females expressing cav 
interference RNA (Table 3.1).  If the reduced male viability is due to the titrating effect of the Y 
chromosome, we would expect that introduction of this compound chromosome into either 
females or males expressing cav interference RNA would reduce viability of animals of either sex 
in comparison to those lacking it.  The results in Table 3.1 showed the C(1;Y) chromosome to 
reduce viability of both males and females by 30% relative to their siblings of the same genotype 
lacking C(1;Y).  But the magnitude of this effect (30%) was not measured as significant (p = 0.09 
> 0.05).  By contrast, the sex of the animals expressing cav RNAi had a significant effect (p < 
0.01) in both classes of progeny, those both with and without C(1;Y).  Male viability was reduced 
2.3-fold in animals expressing cav interference RNA in both classes.  
 
Discussion 
 
The Y-dependent lethality for both male and female bon434/ bon434 mutants indicated that the 
presence of the Y chromosome as a sink for heterochromain proteins, rather than animal’s sex, is 
primarily responsible for the reduced male viability of these mutants.  Beckstead et al. (2005) 
(Beckstead et al., 2005) also observed   bon434/ bon434 female flies carrying additional X-linked 
heterochromatin had reduced viability, and, therefore viability was reduced by introducing any 
additional heterochromatin. Mutants for HOAP differ from bonus in this regard.  Introduction of a 
Y chromosome had a small effect on the viability of both male and female progeny, whether or 
not they expressed cav RNAi.  This effect was significantly smaller than 2.5-fold reduction in 
male viability observed in both C(1;Y)-bearing and C(1;Y)-lacking animals expressing cav 
interference RNA.  When cav interference RNA is expressed, the ratio of female to male progeny 
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in the presence of C(1;Y) (2.31:1), is very close to that in the absence of it (2.30 :1). Taken 
together, these results indicate that an interaction between reduced HOAP levels and the Y 
chromosome is not the primary cause for the reduced viability of males expressing cav 
interference RNA.  This led me to next test my second hypothesis that dosage compensation and 
sex determination are affected in cav mutants and a defect in those processes are responsible for 
the male lethality.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Hui Li 2011 
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Table 3.1. Titrating effect of a heterochromatic Y chromosome does not account for the 
reduced viability of males with reduced HOAP.    
 
Introduction of an extra Y chromosome as C(1;Y) to males and a Y chromosome to females 
expressing cav RNAi did not significantly reduce the animal viability in cross A) in which 
Act5C-GAL4 is contributed by the mothers or B) the cross which Act5C-GAL4 is contributed by 
the fathers.  The numbers for UAS-cav-RNAiF8/CyO and Act5C-GAL4/CyO sibling animals 
were grouped together because they were not phenotypically distinguishable.  (*: n>574, Z=1.7, 
0.1> p > 0.05) (***: n>465, Z=6.6, p < 0.01) 
A) 
♀ C(1;Y)/X; Act5C-GAL4/CyO   X   ♂ X/Y; UAS-cav-RNAiF8/CyO 
Adult Progeny Number X : (1;Y)  ♀ : ♂ 
♀ X/X; UAS-cav-RNAiF8 /Act5C-GAL4  326 1.31 : 1* 2.35 : 1*** 
♀ C(1;Y)/X; UAS-cav-RNAiF8 /Act5C-GAL4 248  2.32 : 1 
♂ X/Y; UAS-cav-RNAiF8 /Act5C-GAL4  139 1.30 : 1  
♂ C(1;Y)/Y; UAS-cav-RNAiF8 /Act5C-GAL4 107   
    
♀ X/X; UAS-cav-RNAiF8 /CyO  686 1.10 : 1 1.14 : 1 
♀ X/X; Act5C-GAL4/CyO 
♀ C(1;Y)/X; UAS-cav-RNAiF8 /CyO 623  1.50 : 1 
♀ C(1;Y)/X ; Act5C-GAL4/CyO 
♂ X/Y; UAS-cav-RNAiF8 /CyO  600 1.44 : 1  
♂ X/Y; Act5C-GAL4/CyO 
♂ C(1:Y)/Y; UAS-cav-RNAiF8 /CyO  416   
♂ C(1;Y)/Y; Act5C-GAL4/CyO 
    
B) 
♀ C(1;Y)/X;  UAS-cav-RNAiF8 /CyO   X   ♂ X/Y;  Act5C-GAL4 /CyO 
Adult Progeny Number X : (1;Y)  ♀ : ♂ 
♀ X/X; UAS-cav-RNAiF8 /Act5C-GAL4  600 0.97 : 1 1.28 : 1 
♀ C(1;Y)/X; UAS-cav-RNAiF8 /Act5C-GAL4 618  1.15 : 1 
♂ X/Y; UAS-cav-RNAiF8 /Act5C-GAL4  467 0.87 : 1  
♂ C(1;Y)/Y; UAS-cav-RNAiF8 /Act5C-GAL4 539   
    
♀ X/X; UAS-cav-RNAiF8 /CyO  1146 0.96 : 1 1.01 : 1 
♀ X/X; Act5C-GAL4/CyO 
♀ C(1;Y)/X; UAS-cav-RNAiF8 /CyO 1193  1.02 : 1 
♀ C(1;Y)/X ; Act5C-GAL4/CyO 
♂ X/Y; UAS-cav-RNAiF8 /CyO  1140 0.97 : 1  
♂ X/Y; Act5C-GAL4/CyO  
♂ C(1:Y)/Y; UAS-cav-RNAiF8 /CyO  1172    
♂ C(1;Y)/Y; Act5C-GAL4/CyO  
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Chapter Four 
Role of Defects in the Sex Determination Pathway in Male Lethality 
 
Introduction 
 
Genetic sex determining systems result in one sex carrying two copies of a sex chromosome 
while the opposite sex carries only a single copy.  Dosage compensation processes allow 
equivalent expression of genes on the sex chromosome in both sexes.  In the X-Y sex determining 
system of Drosophila, transcription from the single X in males is hyperactivated, and defects in 
this process result in male lethality (Lucchesi et al., 2005).   A defect in male dosage 
compensation could occur early in the sex determination pathway in the decision to undertake a 
male vs. female path or late in the mechanics of the dosage compensation process. 
 
The sex lethal (Sxl) gene is the master regulator gene of the sex determination pathway in 
Drosophila and controls genes for both male-specific dosage compensation and sexual 
differentiation.  Sex Lethal (SXL) protein is only active in females, with an X chromosome to 
autosome ratio (X:A) of 1.0 and inactive in males with an X:A ratio of 0.5 (Cline, 1984).  SXL is 
an RNA-binding protein that functions as a splicing regulator of downstream genes in both 
dosage compensation and sexual differentiation, as well as its own transcripts. In the sexual 
differentiation pathway, it controls the female-specific splicing of pre-mRNA from the 
transformer (tra) and transformer 2 (tra-2) genes, which direct female somatic development 
(Burtis et al., 1991; Erdman and Burtis, 1993).  In the dosage compensation pathway, the absence 
of SXL protein in males allows transcripts encoding protein Male Specific Lethal-2 (MSL-2), one 
component of the Dosage Compensation Complex (DCC), to undergo proper splicing and 
translation to form functional protein required to target other non-sex-specific components of the 
DCC to the male X chromosome  (Bashaw and Baker, 1995).  The critical decision in this 
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pathway is made during early embryogenesis with the activation of the Sxl establishment 
promoter (SxlPe) in females only, generating a transcript that is constitutively spliced into a 
mature mRNA encoding functional SXL protein (Keyes et al., 1992).  This SXL protein is 
required for proper female-specific splicing of transcripts produced from the Sxl maintenance 
promoter (SxlPm) later in development in both sexes.  The end result is the production of 
functional SXL protein needed for repression of male-specific splicing and translation of msl-2 
transcripts in females.  Inappropriate expression of SXL in males prevents expression of MSL-2 
needed for male dosage compensation, resulting in male-specific lethality (Lucchesi et al., 2005).  
Loss of SXL expression in females causes inappropriate X chromosome dosage compensation in 
females and female-specific lethality (Lucchesi et al., 2005).   
 
Sxl transcripts are inappropriately spliced in mutants for HOAP or HP1 
 
In order to test the hypothesis that an early defect in male-specific dosage compensation is 
responsible for the reduced viability of males containing reduced levels of HOAP, I first applied 
RT-PCR assays to examine sex-specific splicing of Sxl transcripts in RNA extracted from 
individually sexed cav2248/+ and cav1 embryos that failed to progress to the larval stage (Figure 
4.2).  A GFP reporter expressed from the embryonic twi promoter on the homologous balancer 
chromosome (twi-GFP) was used to identify embryos of the appropriate genotype.  Nucleic acids 
were extracted from individual embryos of the appropriate genotype and used in PCR assays with 
primers for the Y-linked kl-2 gene to determine their sex.  Nucleic acid preparations that 
generated a Y-specific PCR product were identified as male-derived and pooled for purification 
of cav mutant male RNA.  Those that did not give rise to Y-specific PCR products but did 
produce a product for the RpA-70 positive control gene were assumed to be derived from females 
and were pooled for purification of cav mutant female RNA.  RT-PCR assays of each sample 
were then used to monitor the mode of SXL-regulated splicing of SxlPm-derived transcripts.  RpA-
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70 primers were used in similar assays to assure the quality of each RNA template.  Two primer 
pairs (P1/P3 and P2/P3 in Figure 4.2A) were used to detect Sxl transcripts that had undergone 
either the male- or female-specific mode of splicing.  RNA from similarly staged yw embryos was 
used as the control for this experiment.  The results in Figure 4.2B showed that the P1/P3 primer 
pair amplified the expected 269 bp product from the female-specific transcript and 378 bp 
product from the male-specific transcript in RNA from wild type embryos.  The P2/P3 pair 
amplified the expected 215 bp product from the male-specific transcript from wild type male 
embryos only.  By contrast, we were able to detect a minor fraction of the 269 bp P1/P3-primed 
PCR product from the female-specific transcript in the RNA sample from heterozygous cav2248 
males.  We did not, however, amplify the 215 bp product from the male-specific Sxl transcript in 
RNA from female cav mutant embryos.  
 
Because HP1 interacts with HOAP, and HP1 knock-down also preferentially reduces male 
viability, I applied similar RT-PCR assays of Sxl transcripts in RNA isolated from male and 
female larvae that were mutant for the HP1-coding gene [Su(var)205].  Trans-heterozygous 
Su(var)2055/Su(var)20504 larvae were collected from a cross of female Su(var)2055/Act5C-GFP-
CyO to male Su(var)20504/ Act5C-GFP-CyO.  Larval gonad morpoholgy and PCR assays with Y-
linked primers were used to sex individual larvae before RNA was then purified from the 
extracted nucleic acids.  The same primer pairs (P1/P3 and P2/P3 in Figure 4.2A) were used to 
monitor splicing of Sxl transcripts in male and female Su(var)205 mutant larvae.  In contrast to 
what was observed in cav mutants, the assay with the P1/P3 primer pair detected a minor fraction 
of the female-specific transcript in RNA from Su(var)205 mutant male larvae and the P2/P3 
primer pair detected the presence of male-specific Sxl transcripts in RNA from Su(var)205 mutant 
female larvae. 
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Mutations in the HOAP- and HP1-encoding genes genetically interact with Sxl mutations 
 
The presence of aberrant Sxl splice forms in mutants for HOAP and HP1 supports a defect in the 
sex determination pathway in both mutants and also suggests a defect in the critical early decision 
as to whether to express SxlPe.  I, therefore, applied genetic assays to further explore the 
relationship between these heterochromatin proteins and the sex determination pathway.  First, 
the effect of introducing a Sxl loss of function allele (Sxl7B0) into cav2248 heterozygous males was 
examined.  I reasoned that if the male lethality of the cav2248 mutant is due to inappropriate 
expression of Sxl, it should be at least partially rescued by a reduced dose of Sxl.  Although I was 
unable to use genetic markers to identify progeny carrying the Sxl mutation and compare their 
viability to those lacking it, the total male viability of the cav2248 mutant was rescued by either 
paternal or maternal introduction of Sxl7B0 (Table 4.1).   
 
Second, the effect of a maternal mutation in either cav or Su(var)205 on sex-specific viability of 
progeny bearing a loss of function Sxl allele (Sxl7B0 or Sxlnull point null allele) was examined 
(Table 4.2).  Neither Sxl deficiency allele affected the sex-specific viability of progeny from wild 
type mothers.  The results of a cross between cav1 or cav2248 heterozygous females and Sxl/Y were 
similar to those of crosses of either to wild type males.  The cav1 mutation did not cause either 
male or female lethality; the cav2248 mutation reduced the viability of male progeny by 30%, 
similar to its effect when crossed to wt males.  In contrast, the viability of female progeny from 
the cross between Su(var)205 heterozygous females and Sxl/Y males was almost completely 
abolished, regardless of whether the progeny carried the Su(var)205 allele (Table 4.3A).  This 
effect was strictly maternal, as it was not observed in the reciprocal cross (Table 4.3B).  Out of 
three Su(var)205 alleles used in these crosses, only two of them, the null Su(var)2055 containing a 
frameshift mutation after ten amino acids and the C-terminally truncated Su(var)2054 allele, 
exhibited this effect.  The Su(var)2052 allele, which has a point mutation in the conserved 
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chromo-domain responsible for binding di- and tri- MeK9 histone H3, did not reduce female 
viability (Nielsen et al., 2001).  
 
Although maternal mutations in cav did not affect female viability, the maternal effect of 
Su(var)205 mutations on female viability was rescued by simultaneous introduction of a mutation 
in cav and Su(var)205 into the mothers (Table 4.4A & B).  The cav2248 completely rescued the 
female lethality.  The C-terminally truncated cav1 allele, which produces a protein with 
compromised HP1-binding (Badugu et al., 2003; Cenci et al., 2003), was also able to partially 
rescue the female lethality (Table 4.4C & D).  The rescue activity of both alleles was also strictly 
maternal; no effect on female viability was observed when the cav mutation was instead 
introduced through the Sxl mutant fathers.  Interestingly, introduction of the Su(var)2055 mutation 
also rescued the male lethality associated with the cav2248 allele (Table 4.6).   
 
Phosphorylation of HP1 on its hinge domain is required for its heterochromatin association (Zhao 
and Eissenberg, 1999).  To determine whether HP1 phosphorylation plays a role in the sex-
specific viability effects of HP1, I examined the rescuing activity of UAS-driven HP1 transgenes 
that mimic either hyper-phosphorylated (HP1E) or hypo-phosphorylated (HP1G) HP1, in 
comparison to wild type HP1 (HP1wt) (Badugu et al., 2005).  The HP1transgenes used in these 
experiment express proteins contain a FLAG tag at the N-terminus from a heat shock 70 gene 
promoter and UAS-binding site for GAL4 protein (Rorth, 1998).  The HP1E transgene has been 
mutated to change serine and threonine residue in a set of consensus PK-A sites in the hinge 
domain to glutamic acid.  In the HP1G transgene, the same residues have been mutated to glycine 
to mimic hypo-phosphorylation.  The results showed that all three forms were able to partially 
rescue the female viability phenotype of Su(var)205 mothers when a nanos-GAL4 driver was 
used to drive the expression in the maternal germline (Table 4.5).  
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Mutants for HOAP and HP1 inappropriately express SxlPe-derived transcripts 
 
The presence of inappropriately spliced Sxl transcripts in cav and Su(var)205 mutants in the RT-
PCR assays, combined with the genetic interactions between mutations in Sxl, cav, and 
Su(var)205 suggested a role for HOAP and HP1 in sex determination.  The presence of 
inappropriate sex-specific Sxl transcripts in cav and Su(var)205 mutants could either reflect a 
defect in the early decision of whether or not to fire SxlPe or a defect in the process of splicing Sxl 
transcripts in these mutants.  To elucidate the role of HOAP and HP1 at SxlPe, our collaborators in 
Dr. Jamila Horabin’s lab at Florida State University performed in situ hybridization on embryos 
from cav2248 and Su(var)2055 heterozygous parents with probes designed to specifically detect 
transcripts from the two Sxl promoters (SxlPe and SxlPm).  SxlPe-derived transcripts are produced 
only in female wt embryos between cycle 12 -14 (those displaying two in situ hybridization dots 
on the two X chromosomes of females) (Keyes et al., 1992).  This is what observed in wt 
embryos (Figure 5.1).  Embryos from cav2248 parents, however, showed expression of SxlPe-
derived transcripts two cycles earlier in 100% of females and inappropriate expression during 
cycle 13 in at least some nuclei of 95% of male embryos (those displaying one in situ 
hybridization dot per nucleus).  In embryos from Su(var)2055 heterozygous parents, the SxlPe 
expression in ~85% of female embryos was significantly weaker than in wt embryos.  The timing 
of this expression was the same as in wt embryos, and no SxlPe expression was observed in males.  
No effect on SxlPm expression was observed in either mutant; this promoter remained silent at 
these early stages of development. 
 
Discussion 
 
The aberrant presence of the female-form of SxlPm transcripts in male cav mutants could either 
reflect a defect in the early decision not to fire SxlPe in males or a defect in the process of splicing 
the SxlPm transcript.  The first possibility is supported by the in situ hybridization data from our 
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collaborators, Janel Rodriguez and Jamila Horabin at Florida State University.  These 
experiments showed that the SxlPe-derived transcript was inappropriately expressed in male 
embryos and at earlier stages in female embryos from cav2248 parents, supporting a repressing 
activity of HOAP at SxlPe in both sexes.  Consistent with this, an introduction of Sxl7BO mutation 
either paternally or maternally rescued male viability of cav2248 mutant.  The Sxl7B0 mutation is 
not inherited by male progeny when introduced paternally.  Therefore, the increased ratio of male 
progeny may result from rescue of the cav2248 paternal effect on male viability described earlier or 
an effect on female viability that matches the effect on male viability.   
 
Our data suggest a more complicated role for HP1 in regulating Sxl.  Sex-specific Sxl transcripts 
were inappropriately expressed in both sexes of embryos from Su(var)205 mutants.  Again, this 
could either suggest a defect in the early decision to fire SxlPe or a defect in the process of splicing 
Sxl transcripts.  The genetic assays showing the strict maternal effect of the Su(var)205 mutation 
on female viability support an early requirement for HP1 in regulating Sxl.  Moreover, in situ 
hybridization data showing reduced expression of the SxlPe-derived transcript in Su(var)205 
mutant females indicate an activating role for HP1 in regulating SxlPe. The complete rescue of the 
maternal effect of Su(var)2055 mutant on female viability by the introduction of the cav2248 allele 
into these mothers indicates an antagonistic role for HOAP and HP1 in regulating SxlPe.  A 
maternal Su(var)2055 mutation also rescues the male viability defect of the cav2248 mutant, further 
illustrating the antagonistic relationship between the two proteins in regulating SxlPe.  Moreover, 
the partial rescue of the Su(var)205 maternal effect on female viability by the cav1 allele indicates 
cooperative roles for the two proteins in regulating SxlPe, because the protein encoded by the cav1 
allele is compromised for HP1-binding (Badugu et al., 2005; Cenci et al., 2003).  This suggests 
that HP1 plays a role in HOAP-repression of SxlPe.  A repressing activity for HP1 at SxlPe is also 
supported by the RT-PCR assays showing the aberrant expression of the female-form of the SxlPm 
transcript in male Su(var)205 mutant larvae.  The effects of HOAP and HP1 on SxlPe led us to 
41 
 
apply Chromatin Immunoprecipitation (ChIP) assays to determine if these heterochromatin 
proteins directly affect SxlPe expression through physical association with it.  
 
Interestingly, the maternal effect for Su(var)205 on female viability is allele specific; it was not 
observed for the Su(var)2052 allele carrying a point mutation in the MeK9-H3-binding 
chromodomain (Nielsen et al., 2001). This indicates that the MeK9-H3-binding activity of HP1 is 
not required for activation of Sxl.  This does not exclude the possibility that this domain functions 
in HP1 repression at SxlPe. 
 
The partial rescue of lethality for female progeny from Su(var)205 mothers, by UAS-driven HP1 
transgene (HP1wt, HP1E and HP1G) when maternally expressed through the germline-specific 
nanos-GAL4 driver, may indicate that HP1 phosphorylation at these PKA consensus sites does 
not play a role in regulating SxlPe or result from inadequate promoter activity in the germline from 
the pUAST transgenes used in these experiments.  These data also do not rule out the possibility 
that phosphorylation at other HP1 residues is involved.   
 
 
 
 
 
 
 
 
 
 
Copyright © Hui Li 2011 
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Figure 4.1.  Individual heterozygous cav2248 and homozygous cav1 embryos were sexed by 
PCR using primers for the Y-linked kl-2 gene.  Non-quantitative screens of individual cav2248/+ 
heterozygous embryos (top panels) and for cav1 homozygous embryos (bottom panels) to 
determine their sex through PCR assays with primers for RpA-70 as positive control and the Y-
linked kl-2 gene to sex them.  The amount of template used in the RpA70 and kl-2 assays may not 
be identical.  Nucleic acids from a given sex and genotype were then pooled for RNA extraction.   
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Figure 4.2.  SxlPm transcripts are inappropriately spliced in sexed cav and Su(var)205 
mutants.  A) Primer pairs P1/P3 and P2/P3 were designed to amplify sex-specific Sxl transcripts.  
Primers P1 and P3 are anchored in exons found in transcripts of both sexes.  Primer P2 is 
anchored in the male-specific exon of the male SxlPm-derived transcript.  B) RT-PCR assays using 
primer pair P1/P3 (top panel) and P2/P3 (bottom panel) and RNA from (left to right) female and 
male wt and cav1 embryos; female and male wt and cav2248/+ embryos; and female wt and female 
Su(var)2055/ Su(var)20504 larvae; male wt and male Su(var)2055/ Su(var)20504 larvae.  
Arrowheads denote products from inappropriate sex-specific transcripts. 
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Figure 4.3.  SxlPe-derived transcripts are inappropriately expressed in embryos from cav or 
Su(var)205 mutant parents.  A) The SxlPe-derived transcript was expressed only between cycles 
12-14 in wild type (Ore R) female embryos but was inappropriately expressed in 95% of male 
embryos and two cycles earlier in 100% of female embryos from cav2248 heterozygous parents in 
parallel in situ hybridization assays.  B) in situ hybridization assays showed that expression of 
SxlPe-derived transcript was significantly decreased in ~85% of female embryos from Su(var)2055 
heterozygous parents in comparison to wt (Ore R) embryos in parallel in situ hybridization 
assays. 
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Table 4.1.  The male lethality of the cav2248 mutant was rescued by introducing a Sxl loss of 
function mutation either paternally or maternally.   
A) 
♀ cav2248/TM3 X ♂ cav2248/TM3 
 Adult Progeny  ♀ : ♂  
♀ cav2248/TM3  202  1.84 : 1  
♂ cav2248/TM3  110   
 
B) 
  ♀ cav2248/TM3 X ♂ Sxl7BO/Y; cav2248/TM3 
 Adult Progeny  ♀ : ♂  
♀ Sxl7BO/+; cav2248/TM3  138  0.95 : 1***  
♂ cav2248/TM3  145   
 
C) 
♀ Sxl7BO/+; cav2248/TM3 X ♂ cav2248/TM3 
 Adult Progeny ♀ : ♂ 
♀ Total 205 1.04 : 1*** 
♂ Total 197  
 
 
A) The cav2248 allele caused male lethality in heterozygous condition.  B) Introduction of a loss of 
function allele Sxl7BO paternally rescued male viability (n >283, Z=3.851, p < 0.01).   C) 
Introduction of Sxl7BO to the cav2248 mothers rescued male viability (n >402, Z=3.602, p < 0.01).   
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Table 4.2.  A maternal cav mutation did not reduce viability of female progeny lacking one 
functional copy of Sxl.   
♀ cav/TM3  x  ♂ Sxl7B0 /Y 
Adult Progeny   ♀  Sxl7B0/+;  ♂  +/Y;  ♀ : ♂  
  cav/+  TM3/+   cav/+   TM3/+  cav/+   TM3/+  
cav1    199 192 211 205 0.94 : 1  0.94 : 1  
cav2248 (null)   217 196 161 171 1.35 : 1  1.15 : 1  
 
A cross between cav1 heterozygous mothers and Sxl7BO/Y fathers did not cause sex-specific 
lethality; a cross between cav2248 heterozygous females and Sxl7BO/Y males resulted in a slight, 
but insignificant (*: n >367, Z=1.0, p = 0.31), male lethality that resembles that observed when 
cav2248/+ mothers are crossed to wt fathers (Table 2.4 B).  
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Table 4.3.  Su(var)205 mutations have a strictly maternal effect on female viability.    
A) 
♀ Su(var)205/CyO x ♂ Sxlnull /Y 
Adult Progeny  ♀ Sxl7B0/+; ♂ +/Y;  
 Su(var)205/+  CyO/+  Su(var)205/+  CyO/+  ♀ : ♂  
Su(var)2055  14  31  231  230  1 : 16.5***1  
Su(var)2054  82  88  325  281  1 : 4.0***2  
Su(var)2052  154  152  224  192  1 : 1.5  
 
 ♀ Sxlf1/+; ♂ +/Y;  
 Su(var)205/+  CyO/+  Su(var)205/+  CyO/+  ♀ : ♂  
Su(var)2055  2  9  122  120  1 : 22***3  
Su(var)2054  143  141  233  210  1 : 1.6  
 
B) 
♀ Sxl7B0 /FM7 x ♂ Su(var)2055/CyO 
Adult Progeny  ♀ Sxl7B0 /+  FM7/+  ♀ Sxl7B0 /+  FM7/+   
 Suv  CyO  Suv  CyO  Suv  CyO  Suv  CyO  ♀ : ♂ 
 93  85  111  134  120  105  97  57  1 : 1.3 
 
A) Viability of female progeny, was significantly reduced in the crosses between Su(var)205 
mothers and Sxl7BO or Sxlf1 fathers.  (***1: n >506, Z=14.3, p < 0.01) (***2: n >776, Z=11.5, p < 
0.01) (***3: n >253, Z=11.4, p < 0.01).  This effect was allele-specific; the Su(var)2052 allele, 
which is defective for MeK9H3-binding, does not have this effect.  B)  Female viability was not 
affected in the reciprocal cross showing the effect to be strictly maternal.  In addition, effects on 
Su(var)205-lacking as well as Su(var)205-bearing progeny, demonstrate a maternal effect.  
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Table 4.4.  HOAP and HP1 have antagonistic and cooperative effects on Sxl activity. 
A) 
♀ Su(var)2055/CyO; cav2248/+ x ♂ Sxl7B0/Y 
Progeny  Number   
♀  231  1 : 0.87***  
♂  200   
 
B) 
♀ Su(var)2055/CyO x ♂ Sxl7B0/Y; cav2248/+ 
Progeny Number ♀ : ♂ 
♀  8  1 : 23  
♂  187   
   
C) 
♀ Su(var)2055/CyO; cav1/+ x ♂ Sxl7B0/Y 
Progeny  Number  ♀ : ♂ 
♀  42  1 : 4.1***  
♂  172   
 
D) 
♀ Su(var)2055/CyO x ♂ Sxl7B0/Y; cav1/+ 
Progeny Number ♀ : ♂ 
♀  6  1 : 34 
♂  202   
 
 
A) Simultaneous introduction of the cav2248 mutation and Su(var)205 mutation into mothers 
completely rescued the lethality of female progeny from Su(var)205 mutant mothers and Sxl7BO 
fathers (n >461, Z=14.9, p < 0.01).  B) Introduction of the cav2248 mutation through the fathers did 
not rescue the lethality of the female progeny from the Su(var)2055/+ mothers (n >195, Z=2.0, p 
> 0.10).  C) Simultaneous introduction of the cav1 mutation and Su(var)205 mutation into 
mothers partially rescued the lethality of female progeny from Su(var)205 mutant mothers (n 
>214, Z=3.9, p < 0.01).  D) Introduction of cav1 mutation through the fathers failed to rescue the 
lethality of the female progeny from Su(var)2055/+ mothers (n >208, Z=2.7, p > 0.10).        
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Table 4.5.  Maternal expression of HP1 transgenes partially rescued the female-specific 
lethality of progeny from Su(var)205 mothers and Sxl/Y fathers. 
A) 
♀ nanos-GAL4/UAS-HP1wt#F3; Su(var)2055/+   X   ♂ Sxl7BO/Y 
Sexed Progeny   Total  ♀ : ♂  
♀ 59 1 : 2.64***1 
♂ 156 
 
♀ nanos-GAL4/+; Su(var)2055/+; UAS-HP1wt#F14/+   X   ♂ Sxl7BO/Y 
Sexed Progeny   Total  ♀ : ♂  
♀ 37 1 : 4.24***2  
♂ 157 
 
B) 
♀ nanos-GAL4/+; UAS-HP1E#32/Su(var)2055   X   ♂ Sxl7BO/Y 
Sexed Progeny   Total  ♀ : ♂  
♀ 48 1 : 3.71***  
♂ 178 
 
C) 
♀ nanos-GAL4/+; UAS-HP1G#M2/Su(var)2055   X   ♂ Sxl7BO/Y 
Sexed Progeny   Total  ♀ : ♂  
♀ 45 1 : 2.82 *** 
♂ 127 
 
Rescue relative to control female lethal phenotype in Table 4.3A was observed with nanos-
GAL4-directed female germline expression of either A) wild type HP1 (***1: n >215, Z=6.4, p < 
0.01;  ***2: n >194, Z=3.6, p < 0.01) , B) mutant HP1E mimicking hyper-phosphorylated HP1 (n 
>226, Z=4.6, p < 0.01) or C) mutated HP1G mimicking hypo-phosphorylated HP1(n >172, 
Z=5.6, p < 0.01). 
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Table 4.6.  Introduction of the Su(var)2055 mutation to zygotes rescued the reduced male 
viability phenotype of cav2248 heterozygotes. 
♀ Su(var)2055/CyO  x  ♂ cav2248 /TM3Sb 
Adult Progeny Sex Number ♀ : ♂ 
 Su(var)2055/+; cav2248 /+ ♀ 117 1.06 : 1 
 ♂ 110 
CyO/+; cav2248 /+ ♀ 133 2.05 : 1** 
 ♂ 65 
Su(var)2055/+; TM3Sb /+ ♀ 105 1.09 : 1 
 ♂ 96 
CyO/+; TM3Sb /+ ♀ 59 1.05 : 1 
 ♂ 56 
 
The Su(var)205 mutation maternally rescues cav2248 paternal effect, but zygotic mutation is 
needed to rescue the zygotic effect  (n >198, Z=3.2, p < 0.05).   
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Chapter Five 
HOAP and HP1 are Physically Associated with SxlPe 
 
Introduction 
 
The genetic assays and in situ hybridization assays described in Chapter 4 prompted us to apply 
chromatin immunoprecipitation (ChIP) assays to determine whether HOAP or HP1 directly affect 
SxlPe activity by physically associating with SxlPe or other Sxl gene sequence.   
 
I prepared cross-linked chromatin from staged collections of wild type embryos and performed 
immunoprecipitations with antibodies directed against HP1 or HOAP, as well as a non-specific 
IgG control. The ChIP experiments were applied to three different stages of embryos in order to 
monitor both Sxl promoters before and during the time of SxlPe activity (1-3hr) and during SxlPm 
activity (4-18hr).  Chromatin from embryos at a stage that more precisely coincides with SxlPe 
activity (2-3hr) was also examined.   
 
Both HOAP and HP1 are associated with SxlPe 
 
The results, as presented in Figure 5.1, indicated an association of HP1 with the SxlPe proximal 
region and HOAP with both proximal and distal regions of SxlPe in 1-3hr embryos.  Enrichment 
of a given Sxl sequence in each ChIP fraction was measured relative to an RpA-70 gene 
normalizing standard.  A significant 3.5 to 1.9-fold enrichment of sequences in the -101 to +138 
region of SxlPe was observed in the HP1 ChIP fraction.  Sequence from this region was also 
significantly enriched (~2.5-fold) in the HOAP ChIP fraction.  In addition, enrichment of two 
distinct distal regions (centered at -1132 and at -2224) of SxlPe was also observed in the HOAP 
ChIP fraction.  SxlPm sequences were not enriched in either the HOAP or HP1 ChIP fraction at 
this time.  No Sxl sequence was enriched in the IgG ChIP fraction.  I also used an anti-Myc 
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antibody to pull down chromatin from the same staged embryos from a stock expressing Myc-
tagged HOAP from its endogenous locus (Gao et al., 2010).  The results were similar, 
corroborating the specificity of the anti-HOAP antibody in immunoprecipitating Sxl sequences 
(Figure 5.2 D). 
  
The ChIP results of 4-18hr embryos in Figure 5.2 C, showed that neither HOAP nor HP1 is 
associated with the SxlPe proximal sequences after the time of its activity.  However, a significant 
enrichment of SxlPm proximal sequences was observed in the HP1 ChIP fraction at a time when 
SxlPm is active. 
 
The ChIP results for the 2-3hr embryos (Figure 5.2 B) showed a similar association of HOAP and 
HP1 with the +138 region of SxlPe at the time of SxlPe activity.  However, enrichment of the -101 
region was significantly decreased in the HP1 ChIP fraction at this time.  The association of 
HOAP with the -101 and -1132 sequences was reduced but still measured as significant at this 
time.  Neither HOAP nor HP1 was associated with SxlPm at this stage also.   
 
RNAP II association with SxlPe is dependent on HP1 
 
The RT-PCR, genetic and in situ hybridization data indicate an activating role for HP1 at SxlPe.  
To further elucidate the mechanism of this activating role, I examined the effect of a maternal 
Su(var)205 mutation on RNA Polymerase II (RNAP II) association with SxlPe.  Chromatin was 
prepared from embryos collected from a cross between Su(var)2055/CyO females and Sxl7B0/Y 
males at a time when SxlPe is active (2-3hr).  Embryos from this cross were used in this 
experiment because an almost complete female-lethal phenotype was observed in the adult 
progeny.  The hypothesis is that the female-lethal phenotype from this cross is a consequence of a 
requirement for HP1 to either recruit RNAP II or facilitate transcription elongation.  Embryos 
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from a cross between wild type females and male Sxl7B0/Y males at the same developmental stage 
were used in the control for these experiments.  I used three antibodies that recognize specific 
isoforms of RNAP II that differ with respect to phosphorylation of its C-terminal domain (CTD).  
Unphosphorylated CTD associates with the initiation complex at the promoter; the Ser5- and 
Ser2-phosphorylated forms of the CTD heptapeptide repeat associate with the early and late 
phases of transcription elongation, respectively (Komarnitsky et al., 2000).  These experiments 
will allow us to differentiate between the two hypotheses for the role of HP1 in transcription 
activation. 
 
The results, as summarized in Figure 5.3, showed that the unphosphorylated and Ser5-
phosphorylated forms of RNAP II are associated with both SxlPe proximal sequences (-101 and 
+138 fragment) in embryos from wild type mothers.  In embryos from Su(var)205 mutant 
mothers, the association of these two forms of RNA PolII with SxlPe was completely abolished, 
regardless of the state of phosphorylation.  In contrast, the association of these two 
phosphorylated isoforms of RNA PolII with the hunchback promoter, which is also active at this 
time in development, was not affected by the Su(var)205 mutation. 
 
Association of HP1 with SxlPe is dependent on HOAP  
 
The strictly maternal effect of Su(var)205 mutations on viability of female progeny and complete 
rescue of this female lethality by simultaneous introduction of the cav2248 mutation suggested 
antagonistic roles for the maternally supplied HOAP and HP1 in regulating SxlPe prior to the time 
of zygotic expression of their genes.  This is supported by the in situ hybridization assays 
showing SxlPe-derived transcripts to be de-repressed in embryos from cav2248 parents but reduced 
in embryos from Su(var)205 parents.  Rescue of the Su(var)205 maternal effect by the HP1-
binding-defective cav1 allele, however, suggested a cooperative activity for HOAP and HP1 in 
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repressing SxlPe.  This cooperativity could involve a requirement for the partner protein for 
binding by the other to SxlPe.  To determine whether the associations of HP1 and HOAP with 
SxlPe are dependent on each other, I used antibodies against HP1 and HOAP in ChIP assays of 
mutants for their protein partner at 1-3hr of development, the time at which both proteins are 
enriched in the SxlPe proximal region.  The results of the ChIP assays of embryos from 
Su(var)2055 mutants (Figure 5.4) showed that HP1 association with SxlPe proximal sequences was 
significantly reduced (P < 0.05), but the association of HOAP with these sequences was only 
slightly decreased and not measured as significant (0.1 > p > 0.05).  The results of the ChIP 
assays of embryos from cav2248 heterozygous parents (Figure 5.4), by contrast, showed that the 
association of both HP1 and HOAP with SxlPe proximal sequences was almost completely and 
significantly reduced.  HOAP association with the SxlPe -1132 distal sequence was also 
significantly reduced. 
 
Role of histone modifications in regulating SxlPe  
 
Finally, because the repressing role of HP1 might be associated with MeK9H3, as it provides a 
binding site for HP1 in heterochromatin-induced silencing, I also used ChIP assays to monitor 
this histone modification at SxlPe.  The activating role of HP1 could involve a failure to methylate 
K4 on histone H3, because it marks active promoters and permits binding of the basal 
transcription factor TFIID in recruitment of RNA PolII to promoters (Vermeulen et al., 2007).  I, 
therefore, examined the parental effect of Su(var)205 and cav mutations on those histone 
modifications at SxlPe relative to wild type using ChIP assays.  The results in Figure 5.5 showed 
that there was no enrichment of SxlPe sequence relative to the simultaneously active hunchback 
promoter in embryos from wt parents.  However, there was a significant increase in SxlPe 
proximal sequence enrichment in the di- and tri-MeK9H3 ChIP fractions from both cav2248 
mutants and Su(var)2055 mutants.  The association of tri-MeK3H4 with SxlPe relative to the 
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hunchback promoter, was also significantly reduced in Su(var)2055 mutants, but was unaffected 
in embryos from the cav2248/+ parents.  
 
Discussion 
 
The lethal phenotype of female progeny, from the cross between Su(var)205 mothers and Sxl 
fathers, whether or not they carried the Su(var)205 mutation, and only when the Su(var)205 
mutation was contributed by the mothers, suggested an early role for maternal HP1 in regulating 
Sxl activity.  This female lethality was completely rescued by the introduction of the cav2248 
mutation into the Su(var)205 mothers, indicating an antagonistic role of HOAP and HP1 in 
regulating Sxl activity.  These results were supported by the in situ hybridization assays, which 
pointed to a repressing role of HOAP and activating role of HP1 on SxlPe transcription.  In 
addition, defects in SxlPe transcription were observed in a high proportion (>85%) of embryos 
from either cav2248 or Su(var)205 heterozygous parents.  These results prompted me to apply 
ChIP assays to determine if either protein is associated with Sxl sequences in embryos at the time 
of SxlPe transcription.  Although it is not possible to sort embryos of this stage by sex, ChIP 
assays of unsexed embryos can still provide information about whether HOAP and HP1 are 
directly associated with SxlPe.  
 
The ChIP results for wild type embryos at 1-3hr, 2-3hr and 4-18hr suggested a correlation 
between the association of HP1 with SxlPe and the timing of SxlPe activity.  HP1 is enriched in 
proximal SxlPe sequences before and during the time of SxlPe activity.  The association of both 
HP1 and HOAP with SxlPe was completely abolished when SxlPe becomes silent later in 
embryogenesis. Moreover, the RNAP II ChIP results showed the enrichment of SxlPe in Un-CTD 
and Ser5-CTD PolII ChIP fractions to be significantly reduced in embryos from a cross between 
Su(var)205 mutant mothers and Sxl fathers, which results in almost complete female lethality. 
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This further supports the requirement for HP1 in transcription activation and suggests a role for it 
in the initiation rather than elongation phase of transcription.  
 
The genetic assays and in situ hybridization assays, suggest that HOAP functions as a repressor of 
Sxl activity by directly binding SxlPe sequences.  HOAP alone also binds to distal sequences of 
SxlPe suggesting an HP1-independent activity for HOAP from this region.  Furthermore, the ChIP 
assays for the embryos from cav and Su(var)205 heterozygous parents showed a significant 
reduction in the association of HP1 with SxlPe in cav2248 mutant parents.  A smaller, but 
insignificant, reduction in the association of HOAP with SxlPe was also observed in Su(var)205 
mutant parents.  These results indicate a dependence of HP1 on HOAP for its association with 
SxlPe and a possible stabilizing effect of HP1 on HOAP in its association.  
 
Neither di- nor tri-MeK9H3 is associated with SxlPe before and during SxlPe activity in wild type 
embryos, indicating that this modification is not required for HP1 association at SxlPe.  This is 
consistent with the genetic data showing the MeK9H3-binding-defective Su(var)2052 allele does 
not have a maternal effect on viability of female progeny that are deficient for one copy of Sxl.  
The significant increase of the di- and tri-MeK9H3 at SxlPe in the two mutants relative to wild 
type could result from a feedback mechanism to compensate for the loss of HP1 or reflect an 
indirect global effect of the Su(var)205 mutation on spreading of MeH3K9 modifications into 
euchromatic regions that was previously reported by Reuter et al. (2005).  It could even indicate a 
role for the HOAP/HP1 complex in preventing SU(VAR)3-9 K9-H3 methyltransferase activity at 
SxlPe in wild type embryos.   
 
 
 
Copyright © Hui Li 2011 
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Figure 5.1.  HOAP and HP1 are associated with the proximal and distal regions of SxlPe in 
the 1-3 hr wt embryos.  Fold enrichment of specific Sxl sequence relative to the RpA-70 
sequence (Y axis) in the HOAP- (red solid line) and HP1- (green dotted line) ChIP fractions is 
plotted along the Drosophila genome (GBrowse) (Tweedie et al., 2009) coordinates for the Sxl 
locus (X axis).  Black boxes mark the positions of each PCR fragment examined by real time 
quantitative PCR.  Position of the consensus binding sites for both X-linked transcription 
activators (+ E boxes) and autosomal repressors (-E-boxes) are shown (Jinks et al., 2003).  The 
position of SxlPe and SxlPm –derived transcripts are shown beneath their corresponding sequence in 
the molecular map.  Significance of enrichment (* = p < 0.05). 
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   A)                                            B)                                             C)  
    D)                                
 
 
 
 
 
 
Figure 5.2.  Developmental profile of the association of HOAP and HP1 with SxlPe.  Bar 
graphs represent fold-enrichment of SxlPe sequences (+138, -101, -1132, -5094, -5331) in HP1- 
(blue bars) and HOAP- (red bars) ChIP fractions relative to the input after normalization against 
that for the RpA-70 standard in A) 1-3 hr, B) 2-3hr and C) 4-18hr wild type embryos.  D) Bar 
graphs represent fold-enrichment of Sxl sequences (+138, -101, -5094, -5331) in HP1- (blue bars) 
and Myc- (red bars) ChIP fractions relative to the input after normalization against that for the 
RpA-70 sequence standard in 1-3 hr embryos from N-MycHOAP transgenic parents.  For each 
ChIP, at least two replicates were done.  The standard errors between replicates are represented 
by error bars.  Significance of enrichment (* = p < 0.05, ** = p < 0.01); Significance of difference 
from 1-3hr wt (# = p < 0.05, ## = p < 0.01)  
 
 
1-3 hr 
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Figure 5.3.  RNAP II association with SxlPe was completely abolished in embryos from 
Su(var)2055 mothers and Sxl7BO/Y fathers.  Bars graphs represent fold-enrichment of (+138) 
and (-101) SxlPe and hunchback (hb) proximal promoter sequences in the unphosphorylated 
RNAPII (blue bar), Ser2-phosphorylated form of RNAP II (red bar) and Ser5-phosphorylated 
RNAP II (green bar) ChIP fractions relative to the input after normalization against the RpA-70 
standard.  For each ChIP, at least two replicates were done.  The standard errors between 
replicates are represented by error bars.  Significance of enrichment (* = p < 0.05, ** = p < 0.01); 
Significance of difference from wt (# = p < 0.05, ## = p < 0.01).   
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A)                                                               B) 
 
Figure 5.4.  HP1 association with SxlPe is dependent on HOAP, whereas HOAP association 
with SxlPe is only moderately affected in mutants for HP1.  Bar graphs represent fold-
enrichment of SxlPe sequences (+138, -101, -1132, -5094, -5331) in HP1- (blue bars) and HOAP- 
(red bars) ChIP fractions relative to the input after normalization against that for the RpA-70 
standard in chromatin from:  A) Su(var)2055 heterozygous parents and B) cav2248 heterozygous 
parents.  For each ChIP, at least two replicates were done.  The standard errors between replicates 
are represented by error bars.  Significance of enrichment (* = p < 0.05, ** = p < 0.01); 
Significance of difference from wt (# = p < 0.05, ## = p < 0.01) 
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Figure 5.5.  Both di- and tri-MeH3K9 modifications are increased at SxlPe in embryos from 
cav2248 or Su(var)2055 heterozygous parents; tri-MeH3K4 is also decreased at SxlPe  in 
Su(var)2055 mutant.  Bar graphs represent enrichment of SxlPe -101 sequence in tri-MeH3K4- 
(blue bar), di-MeH3K9- (red bar) and tri-MeH3K9- (green bar) ChIP fractions in chromatin from:  
wt, cav2248 heterozygous and Su(var)2055 heterozygous parents.  Enrichment of SxlPe sequence is 
relative to the hb promoter sequence.  For each ChIP, at least two replicates were done.  The 
standard errors between replicates are represented by error bars.  Significance of enrichment (* = 
p < 0.05, ** = p < 0.01); Significance of difference from wt (# = p < 0.05, ## = p < 0.01) 
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Chapter Six 
Other Roles for HOAP in Sex Determination 
 
In addition to the maternal role for HOAP in regulating SxlPe, the cav RNAi expression data 
indicate zygotic requirements for it in male viability.  The male lethal phenotype of loss of 
function mutants for HP1 and the HP1-interacting SU(VAR)3-7 protein is associated with 
delocalization of dosage component proteins on a shortened and bloated X-chromosome in males 
(Spierer et al., 2005).  Therefore, a role for HOAP in the sex determination process is addressed 
in this chapter.  A role for HOAP in male-specific gene expression could also underlie this 
zygotic requirement for HOAP in male viability.  RT-PCR assays of testis-specific genes that had 
reduced transcript levels in the cav1 expression profiling study will also be used to determine if 
under-representation of males in the cav1 RNA sample is the sole cause of the reduced transcripts 
levels. 
 
HOAP in dosage compensation 
 
To compensate for the presence of only one X chromosome in males and two in females, 
Drosophila males hyper-activate gene expression on their single X chromosome by altering the 
chromatin of the X chromosome to make it more open to the transcription machinery through a 
process involving histone acetylation and non-coding RNA (Gorman and Baker, 1994).  This 
process is mediated by the Dosage Compensation Complex (DCC), which is made up of proteins 
from six male-specific lethal genes [maleless (mle), male-specific lethal-1 (msl-1), male-specific 
lethal-2 (msl-2), male-specific lethal-3 (msl-3), male-absent on the first (mof) histone 
acetyltrasferase and JIL-1 kinase] and two non-coding RNAs from the X-linked roX1 and roX2 
genes (roX = RNA on the X) (Gorman and Baker, 1994) (Franke and Baker, 2000).  Dosage 
Compensation is achieved by the binding of the DCC to hundreds of sites along the male X 
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chromosome.  Accordingly, histone H4 acetylated at lysine 14 (H4Ac16), a marker for 
transcriptionally active chromatin, is enriched at these sites in males (Bone et al., 1994).  The core 
component of the DCC is MSL-2, which directs other non-sex-specific components to the X 
chromosome.  In females, translation of the msl-2 transcript is repressed by SXL protein to 
prevent dosage compensation (Bashaw and Baker, 1997) (Kelley et al., 1997).  Decreased levels 
of MSL-2 reduce the number of binding sites of the DCC on the X chromosome and cause male 
specific lethality (Demakova et al., 2003).  Over-expression of MSL-1 or MSL-2 causes de-
localization of the DCC to binding sites on the autosomes and the chromocenter and female 
specific lethality (Demakova et al., 2003).   
 
The male lethal phenotype of loss of function mutants for HP1 or the HP1-interacting 
SU(VAR)3-7 protein is associated with a shortened and bloated X-chromosome phenotype in 
males, similar to the phenotype observed with over-expression of MSL-2 (Spierer et al., 2005).  
This phenotype is suppressed by a mutation in mle, the gene encoding the RNA helicase 
component of the DCC (Spierer et al., 2005).  Spierer et al. (2008) (Spierer et al., 2008) showed 
decreased levels of maternal SU(VAR)3-7 reduced expression of a white reporter gene, an X-
linked gene that is dosage compensated when inserted as a transgene onto an autosome.  MSL-1 
and MSL-2 were also delocalized away from the X chromosome to the chromocenter in Su(var)3-
7 mutants.  Zygotic loss of both copies of Su(var)205 produces a similar phenotype.  These 
phenotypes are similar to the effects of over-expressing msl-2 (Demakova et al., 2003).  Animals 
over-expressing SU(VAR)3-7 had a hyper-condensed X chromosome phenotype, and MSL-1 and 
MSL-2 were delocalized to autosomal sites, similar to what is observed in loss of function 
mutants for roX-1, roX-2 or MSL-2 (Oh et al., 2003).  These results suggest an antagonistic 
relationship between heterochromatin and dosage compensation proteins on the X chromosome, 
and the male lethality for Su(var)3-7 mutants is a result of a loss of balance between these 
antagonistic activities in dosage compensation.  
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These results suggested that the enhanced lethality of cav mutant males could result from failure 
to properly antagonize this process, as has been observed for both HP1 and SU(VAR)3-7.  The 
data presented in earlier chapters are consistent with de-repression of SxlPe in the cav mutant 
males being responsible for inappropriately preventing expression of dosage compensation in 
males.  Therefore, the following two hypotheses will be tested: 1) An antagonistic role of HOAP 
in dosage compensation process causing MSL-2 redistribution from a bloated X chromosome to 
the chromocenter; 2) Down-regulation of MSL-2 through effects of HOAP on SxlPe resulting in 
loss of MSL-2 from a hyper-condensed X chromosome to the autosomes. 
 
Results 
 
In an attempt to determine whether loss of HOAP causes an effect that is more similar to that of 
the Su(var)3-7 mutant, which resembles MSL-2 over-expression, or more similar to loss of MSL-
2, as predicted to occur with de-repression of SxlPe, I examined MSL-2 immunostaining on 
polytene chromosomes from salivary glands of male cav1 third-instar larvae (Figure 6.1).  We 
found the salivary glands from cav1 male larvae to be very small and difficult to squash, making it 
difficult to identify each chromosome in the spreads.  I did not observe the X chromosome to be 
either shortened or bloated in the cav1 mutant.  MSL-2 appeared to be properly associated with a 
single chromosome, which we presumed to be the X chromosome, in some squashes from cav1 
mutant males.  Reduced MSL-2 staining on this chromosome was, however, observed in the 
majority (67%) of chromosome spreads.  However, given the difficulty with obtaining good 
chromosome spreads from the cav1 mutant, this reduced staining could be a technical artifact. 
     
As a second assay for determining whether HOAP antagonizes dosage compensation or is 
required to express DCC components, we hypothesized that introducing a loss of function 
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mutation for one of the DCC components into the cav2248 mutant should exacerbate its male 
lethality.  Over-expressing MSL-2, by contrast, should partially restore male viability. 
The results in Table 6.1, show that introduction of a loss of function msl-21 mutation (Zhou et al., 
1995) slightly enhanced the male lethality of cav2248 mutant, but this effect was not significant (p 
> 0.05).  To over-express MSL-2, a transgene for msl-2 carrying mutations in the SXL-binding 
sites in its 5’ and 3’ UTR, making it immune to translational repression by SXL (Kelley et al., 
1997), was introduced into animals expressing cav interference RNA and the ratio of male to 
female progeny examined.  This transgene (NOPU) is capable of rescuing the male lethality of 
msl-2 mutants and one copy of it in females does not result in female-specific lethality (Kelley et 
al., 1997).  As shown in Table 6.2, the introduction of the MSL-2 transgene rescued male 
viability in comparison to the control sibling males lacking it (Z = 2.3, p < 0.05).  However, the 
poor survival of all sibling control animals expressing cav RNAi makes these results difficult to 
interpret.   Furthermore, the ratio of males to females (1:2.2) in the cav-RNAi-expressing animals 
containing the MSL-2 (NOPU) transgene is not significantly different from that in the absence of 
it (Z = 0.6, p > 0.05).    
 
HOAP in sex-specific gene expression 
 
Another possible sex-specific zygotic role for HOAP that could underlie the zygotic effect of 
expressing cav RNAi on male viability could be one of regulating male-specific (including testis-
specific) gene expression.  To determine whether the enrichment of testis-specific genes in the set 
of genes with reduced transcript levels in the expression profiling study reflects a direct 
requirement for HOAP in testis-specific gene expression rather than an indirect effect of males 
being under-represented, I applied semi-quantitative RT-PCR assays to a subset of testis-specific 
genes with altered expression in the microarray study to RNA from individually sexed male and 
female cav1 larvae.   
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Using the RpA-70 gene as normalizing standard, the RT-PCR assays (Figure 6.2) showed the 
transcript levels of three out of four testis-specific genes with reduced levels in the expression 
profiling study also had reduced levels in individually sexed cav1 male larvae; transcript levels 
from CG2082 did not appear to be reduced in the cav1 male RNA.  In contrast, transcript levels of 
all four non-testis-specific genes were unchanged in cav1 males relative to wt males.  RT-PCR 
assays of three non-testis-specific genes that had elevated levels in the cav1 expression profiling 
study were also used to monitor levels of these transcripts in both male and female cav1 mutant 
larvae, relative to wt males and females (Figure 6.3).  Only one of the three genes appeared to 
have increased transcript levels in cav1 females (CG5550) or males (CG5778), relative to wt 
females or males.  
 
Discussion 
 
The MSL-2 immunostaining results shown in Figure 6.1 appeared to show normal distribution of 
MSL-2 in cav1 mutant males.  However, it only represented ~1/3 of the polytene chromosome 
squashes being examined.  The other ~2/3 had no staining, which could simply reflect the poor 
quality of chromosome spreads from cav1 mutant larvae.  It is, therefore, not possible to draw 
firm conclusions from these experiments. 
 
The genetic assay shown in Table 6.1 indicated that the introduction of the msl-21 mutation into 
cav2248 progeny through their mothers only slightly rescued viability of the male progeny.  I was 
unable to cross cav2248/TM3 mothers to msl-21/CyO; cav2248/TM3 fathers because males carrying 
both mutations (cav2248 and msl-21) did not survive, which may indicate that the msl-21 and cav2248 
mutations have a synergistic effect on male viability.  The results of the crosses with the 
transgene for MSL-2 (NOPU) are even more difficult to interpret.  The poor survival of the 
sibling control animals expressing cav RNAi, but lacking the MSL2 transgene, complicates the 
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interpretation.  MSL-2 Western blotting could provide an alternative approach to determining the 
effect of the cav mutation on MSL-2 expression, as predicted to occur with inappropriate 
activation of SxlPe.  Larger effects are expected to be observed in mutant cav male embryos, rather 
than mutant cav larvae.  However, my method of sexing cav1 embryos requires a PCR assay of 
purified nucleic acids, thus, destroying the proteins. 
 
The semi-quantitative RT-PCR assays showed a select group of testis-specific genes with reduced 
expression in the microarray study to also have reduced transcript levels in the individually sexed 
cav1 male larvae.  In contrast, expression of a select group of non-testis-specific genes with 
increased transcript levels in the microarray study was not affected in the sexed male cav1 larvae 
(Figure 6.2 & 6.3).  The magnitude of change in their transcript levels for these selected genes did 
not completely match what was observed in the microarray study, suggesting a more quantitative 
assay, such as real time quantitative RT-PCR, may be needed.  Therefore, the large bias towards 
testis-specific genes in the set of genes with reduced transcript levels may reflect a sex 
transformation of male gonad, in addition to under-representation of males in the cav1 mutant 
larvae.  Both effects could occur as a result of SxlPe mis-regulation.  Mutations in Sxl and other 
genes in the sex determination pathway in the male soma are known to induce sex 
transformations in the gonad (Janzer and Steinmann-Zwicky, 2001).  To address this possibility, I 
will use the male germline marker-1-lacZ (mgm-1-lacZ) enhancer trap line that is expressed 
specifically in male germ cells to test the male identity of the gonadal cells in cav1 mutant  males 
(Janzer and Steinmann-Zwicky, 2001).  I will also use the ovo-lacZ reporter for female germline 
cells to test the female identity of these cells (Niki and Mahowald, 2003).    
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Figure 6.1.  MSL-2 displayed normal distribution in polytene chromosomes from male cav1 
mutants.  The top panel shows DAPI staining (DAPI), MSL-2 immunostaining (MSL-2), and 
overlay of DAPI and MSL-2 immunostaining of polytene chromosomes from cav1/TM6Tb male 
larvae. The bottom panel shows DAPI staining (DAPI), MSL-2 immun0staining (MSL-2), and 
overlay of DAPI and MSL-2 immunostaining of polytene chromosomes from cav1/cav1 male 
larvae. 
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A) Testis-specific genes identified in the 
cav1 microarray 
B) Non-testis-specific genes identified in the cav1 
microarray 
Gene 
name 
Log2
R 
P  
value 
Expression 
Pattern 
Gene name Log2
R 
P 
value 
Expression 
Pattern 
CG2082 -2.77 0.02 Testis CG6173/kal-1 -10.8 0.025 Head/fat body 
CG32459 -4.84 0.049 Testis CG4180 -6.78 0.006 Multiple 
CG4669 -5.29 0.006 Testis CG3054 2.2 0.006 Multiple 
CG8701 -7.77 0.032 Testis SOCS36E 2.37 0.031 Multiple/rare 
CG8914 -9.27 0.002 Testis CG11149 10.32 0.008 Midgut 
 
 
Figure 6.2.  Testis-specific genes with reduced transcript levels remain affected in sexed 
male cav1 larvae.  Semi-quantitative RT-PCR assays of a subset of: A) testis-specific genes with 
decreased (log2R < -2.0) transcript levels or B) non-testis-specific genes with increased (log2R > 
2.0) transcript levels in the microarray study using a 10-fold dilution series of RNA from wt and 
individually sexed male cav1 larvae. The RpA-70 gene serves as the normalizing standard. 
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Non-testis-specific genes with elevated transcript levels in the expression profiling study 
Gene name Log2R P value Expression Pattern 
CG5550 9.83 0.006 midgut 
CG5791 48.67 0.048 rare 
CG5778 19.63 0.037 rare 
 
Figure 6.3.  Non-testis-specific genes with increased transcript levels do not remain affected 
in sexed cav1 larvae.  Semi-quantitative RT-PCR assays of a subset of non-testis-specific genes 
with increased (log2R > 2.0) transcript levels in the microarray study using a 10-fold dilution 
series of RNA from wt and cav1 male larvae and wt and cav1 female larvae.  The RpA-70 
(RPA70) gene serves as the normalizing standard. 
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Table 6.1.  Introduction of an msl-21 loss-of-function allele slightly exacerbated the reduced 
male viability of cav2248 heterozygotes.   
 
The ratio of ♀ : ♂ for cav2248/TM3 in the presence (1.41:1) or the absence (1.33:1) of msl-21 is 
not significantly different (Z=0.149, p > 0.05).  The ratio of ♀ : ♂ for cav2248/Lyr in the presence 
(1.53:1) or the absence (1.26:1) of msl-21 is not significantly different either (Z=0.947, p > 0.05). 
 
 
 
 
 
 
 
 
 
 
♀ cav2248/TM3   X   ♂ msl-21/CyO; Lyr/TM3 
Progeny  Sex Total  ♀ : ♂  
msl-21/+; cav2248/TM3  ♀ 114 1.41 : 1   
 ♂ 81 
CyO/+; cav2248/TM3  ♀ 81 1.33 : 1  
 ♂ 61 
msl-21/+; cav2248/Lyr  ♀ 147 1.53 : 1  
 ♂ 96 
CyO/+; cav2248/Lyr  ♀ 118 1.26 : 1  
 ♂ 94 
msl-21/+; Lyr/TM3 ♀ 158 1.19 : 1  
 ♂ 133 
CyO/+; Lyr/TM3 ♀ 127 1.06 : 1  
 ♂ 120 
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Table 6.2.  Over-expression of MSL-2 rescued the lethality of males expressing cav 
interference RNA, although the viability of all sibling control animals was also affected.   
♀ Act5C-Gal4/CyO   X   ♂ UAS-cav-RNAiF8/CyO; P[MSL-2]/TM3 
Progeny  Sex Total  ♀ : ♂  
Act5C-GAL4/UAS-cav-RNAiF8; P[MSL-2]/+  ♀ 103 2.19 : 1*  
 ♂ 47 
Act5C-GAL4/UAS-cav-RNAiF8; TM3/+  ♀ 15 0 
 ♂ 0 
UAS-cav-RNAiF8/CyO; P[MSL-2]/+   ♀ 92 0.95 : 1  
 ♂ 97 
Act5C-Gal4/CyO; P[MSL-2]/+    ♀ 96 0.97 : 1  
 ♂ 99 
UAS-cav-RNAiF8/CyO; TM3/+ ♀ 32 1.07: 1  
 ♂ 30 
 Act5C-Gal4/CyO; TM3/+  ♀ 0 0 
 ♂ 0 
 
The ratio of ♀ : ♂ for Act5C-GAL4/UAS-cav-RNAiF8 in the presence (2.19:1) or the absence 
(15:0) of P[MSL-2] is significantly different (Z=2.263, p < 0.05).  The ratio of ♀ : ♂ for Act5C-
GAL4/UAS-cav-RNAiF8 in the presence (2.19:1) or the absence (2.49:1) (Table 2.2) of P[MSL-
2] is not significantly different (Z=0.572, p > 0.05). 
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Chapter Seven 
Sex-specific Roles for Other HP1- and HOAP-interacting Proteins 
 
Introduction 
 
Chapter 5 showed that association of RNAP II with SxlPe was completely abolished in the 
Su(var)205 mutant background, suggesting a positive role of HP1 in RNAP II recruitment or 
stability at SxlPe.  This activity might involve homologues of two S. pombe proteins that regulate 
the repressive and activating activities of Swi6 (HP1) in heterochromatin, Epe1 (Umbrea) and 
Chp1 (CG11033).  In addition, a role for HOAP in testis-specific gene expression could involve 
another HOAP-interacting protein encoded by the testis-specific CG14011 gene.   
 
Epe1 is a K9-H3 de-methylase in S. pombe that has been shown to be recruited to 
heterochromatic loci by the HP1 homolog Swi6 to promote RNAP II binding to heterochromatic 
repeats (Zofall and Grewal, 2006).  Epe1 competes with the chromodomain protein Chp1 for 
association with Swi6; Epe1 activates transcription of these repeats, whereas Chp1 represses 
transcription.  The Drosophila Umbrea gene encodes a chromo shadow domain protein that was 
identified in a high-throughput genome-wide yeast two-hybrid screen of Drosophila gene 
products (Giot et al., 2003) and later shown to interact with HOAP and HP1 at telomeres and 
have a telomere fusion phenotype when knocked down by interference RNA (Joppich et al., 
2009).  I, therefore, tested the effect of knocking down Umbrea or CG11033 on sex-specific 
viability.   
 
In addition, I did similar assays with RNAi-knockdown and targeted knock out of the CG14011 
gene, whose product was also identified as a HOAP-interacting protein in the genome-wide yeast 
two-hybrid assay (Giot et al., 2003) and has testis-specific expression.   I hypothesized that 
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HOAP and CG14011 may cooperate in the testes to activate testis-specific genes, whereas HOAP 
and HP1 cooperate in non-testis tissues to silence these genes.   
 
Determining the role of the Epe1 homolog-CG11033 product  
 
To determine if the Epe1-like CG11033 plays a role in the activation of SxlPe by HP1, I first used 
the GAL4/UAS binary system to drive the ubiquitous expression of a UAS-CG11033 interference 
RNA transgene generated by the Vienna Drosophila RNAi Center (Dietzl et al., 2007).  Using the 
Act5C-GAL4 driver to express CG11033 RNAi, a ~2 fold reduction in male viability was 
observed only in the progeny carrying both the GAL4 driver and CG11033 RNAi transgene 
(Table 7.1A).  Early zygotic expression of CG11033 RNAi though the nullo-GAL4 driver caused 
a similar ~2 fold reduction in male viability only in animals carrying both transgenes (Table 
7.1B).  No sex-specific lethality was observed when CG11033 RNAi was driven by the germline-
specific nanos-GAL4 either paternally or maternally and crossed to wild type animals (Table 
7.1C & D).  A cross between mothers carrying both the nanos-GAL4 driver and CG11033 RNAi 
to Sxl/Y fathers also did not result in any sex-specific lethality (Table 7.1E).  Therefore, the 
effects on male viability seen only with expression of CG11033 RNAi through the Act5C- and 
nullo-GAL4 drivers appears to be a completely zygotic one and are likely to occur after the time 
of SxlPe activation in the early embryo.   
 
Determine the role of Umbrea 
 
To determine if Umbrea is required for sex-specific viability, I used the strong ubiquitous Act5C-
GAL4 driver to express a UAS-Umbrea RNAi transgene generated by the Vienna Drosophila 
RNAi Center (Dietzl et al., 2007) and observed a lethal phenotype for both males and females, 
only in animals carrying both the GAL4 driver and UAS-Umbrea RNAi transgene (Table 7.2A).  
Expression of Umbrea interference RNA in the female germ-line through a nanos-GAL4 driver 
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reduced viability of male progeny (Table 7.2 D).  Interestingly, the reverse phenotype was 
observed when mothers of this genotype were crossed to Sxl mutant father; female viability was 
reduced (Table 7.2E).   In contrast, paternal expression of Umbrea interference RNA by nanos-
GAL4 driver had no effect on sex-specific or sex non-specific viability (Table 7.2C).  Embryonic 
expression of Umbrea interference RNA through the nullo-GAL4 driver also did not show either 
male or female lethality (Table 7.2B).  These results point to an early requirement for Umbrea in 
sex-specific viability that resembles that of HP1.   
 
Determining the role of the testes-specific CG14011 HOAP-interacting protein 
 
Ubiquitous expression of a UAS-transgene for CG14011 interference RNA generated by the 
Vienna Drosophila RNAi Center (Dietzl et al., 2007) by the Act5C-GAL4 driver did not reduce 
either male or female viability (Table 7.3A).  I also used ends-in targeted recombination 
technology to make a knock-out mutation in CG14011.  I observed no reduction in either male or 
female progeny in this presumed knockout mutant for CG14011 (CG14011KO).  I also combined 
this mutation with the cav2248 mutation to examine it for genetic interaction with cav.  The results 
in Table 7.3, showed that introduction of one copy of CG14011KO allele into cav2248 fathers 
rescued the viability of male progeny only carrying the cav2248 mutation, in comparison to their 
viability in the cross of Table 2.4C, in the absence of the CG14011KO allele (Z = 3.659, n >312, 
p < 0.01).  Viability of male progeny carrying both the CG14011KO and cav2248 alleles, in 
comparison to their siblings lacking CG14011KO, was reduced, but not to significant levels (Z = 
1.415, n >137, p > 0.05).  It should also be noted that knockout of CG14011 in this stock has not 
been confirmed by PCR.   
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Discussion 
 
The genetic assays described in this chapter attempted to examine the interaction of cav with 
CG14011 and determined the sex-specific viability phenotypes of knocking down CG11033 and 
Umbrea.  RNAi knockdown of CG11033 produced a zygotic male lethal phenotype that is 
presumably not related to SxlPe activity.  The Umbrea RNAi knockdown phenotype was most 
consistent with an early requirement for Umbrea for sex-specific viability that is similar to that of 
HP1.  Therefore, if the knockdown of Umbrea is specific to it, and does not also affect 
Su(var)205 as an off-target, these phenotypes suggest a role for it in SxlPe regulation.   The 
targeted recombination knock-out allele for CG14011 also appeared to rescue the cav2248 paternal 
effect (Z = 3.659, n >312, p < 0.01).  It will, however, be necessary to confirm knockout of the 
CG14011 gene in this allele through PCR assays.    
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Table 7.1.  Effects of CG11033 inteference RNA expression on sex-specific viability. 
 
Viability of male progeny was reduced by expression of CG11033 interference RNA through the: 
A) ubiquitous Act5C-GAL4 driver (*1: Z = 4.2, n >174, p < 0.01) or the B) embryonic nullo-
GAL4 driver (*2: Z = 4.1, n >143, p < 0.01).  Sex-specific viability was not affected when the 
germline-specific nanos-GAL4 driver was used to drive expression of CG11033 in: C) males 
crossed to wild type females, D) females crosses to wild type males, or E) females crossed to Sxl-
/Y males.   
 
A) 
♀ Act5C-GAL4/CyO   X   ♂ UAS-CG11033-RNAi (2) 
Progeny  Total  ♀ : ♂ 
Act5C-GAL4/UAS-CG11033-RNAi  ♀ 119 2.16 : 1*1 
 ♂ 55 
CyO/UAS-CG11033-RNAi /+ ♀ 98 0.87 : 1 
  ♂ 113 
    
B)  
♀ nullo-GAL4 (2) x ♂ UAS-CG11033-RNAi (2) 
Progeny  Total  ♀ : ♂ 
nullo-GAL4/UAS-CG11033-RNAi  ♀ 99 2.25 : 1*2 
 ♂ 44 
 
C) 
♀ yw x ♂ nanos-GAL4/UAS-CG11033-RNAi/+ 
Progeny  Number ♀ : ♂ 
♀  total 94 0.93 : 1 
♂  total 101 
 
D) 
♀ nanos-GAL4/UAS-CG11033-RNAi x ♂ yw 
Progeny  Number ♀ : ♂ 
♀  total 73 1.16 : 1  
♂  total 63 
 
E) 
♀ nanos-GAL4/UAS-CG11033-RNAi/+ x ♂ Sxl7BO/Y 
Progeny  Number ♀ : ♂ 
♀   total 194 1.11 : 1  
♂   total 174 
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Table 7.2.  Effects of Umbrea inteference RNA expression on sex-specific viability. 
A) 
♀ Act5C-GAL4/CyO   X   ♂ UAS-Umbrea-RNAi/TM3 
Progeny   Total  ♀ : ♂  
Act5C-GAL4/+; UAS-Umbrea-RNAi /+  ♀ 0 0 
 ♂ 0 
CyO/+; UAS-Umbrea-RNAi /+ ♀ 150 1.34 : 1 
  ♂ 112 
Act5C-GAL4/+; TM3/+ ♀ 24 0.63 : 1 
 ♂ 38 
CyO/+; UAS-Umbrea-RNAi/+ ♀ 0 0 
 ♂ 0 
B) 
♀ nullo-GAL4 (2) x ♂ UAS-Umbrea-RNAi/TM3 
Progeny  Sex Number ♀ : ♂ 
nullo-GAL4/+; Umbrea-RNAi/+ ♀   36 0.95:1 
 ♂ 38 
nullo-GAL4/+; TM3/+ ♀   43 1.23:1 
 ♂ 35 
C) 
♀ yw x ♂ nanos-GAL4/+; UAS-Umbrea-RNAi/+ 
 Progeny Number  ♀ : ♂ 
♀  Total 62 0.90 : 1 
♂  Total 69  
 
D)                               ♀ nanos-GAL4/+; UAS-Umbrea-RNAi/+ x ♂ yw 
 Progeny Number  ♀ : ♂ 
♀  Total 105 2.84 : 1*1 
♂  Total 37  
 
E)                               ♀ nanos-GAL4/+; UAS-Umbrea-RNAi/+ x ♂ Sxl7BO/Y 
 Progeny Number  ♀ : ♂ 
♀  Total 48 1 : 2.19*2 
♂  Total 105  
 
Crosses were used to determine the effect of Umbrea interference (Umbrea RNAi) expression on 
sex-specific viability when driven by the A) ubiquitous Act5C-GAL4 driver, B) embryonic nullo-
GAL4 driver, and the nanos-GAL4 driver in C) males crossed to wild type females, D) females 
crossed to wild type males (*1: Z = 4.0, n >142, p < 0.01), and E) females crossed to Sxl7BO/Y 
males (*2: Z = 3.1, n >153, p < 0.05). 
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Table 7.3.  Genetic assays to determine the role of CG14011 in sex-specific lethality.   
A) 
♀ Act5C-GAL4/CyO   X   ♂ UAS-CG14011-RNAi (3) 
Progeny   Total  ♀ : ♂  
Act5C-GAL4/+; UAS-CG14011-RNAi /+  ♀ 136 1.04 : 1  
 ♂ 131 
CyO/+; UAS-CG14011-RNAi /+ ♀ 125 1.30 : 1 
  ♂ 96 
 
B) 
♀ cav2248/TM3   X   ♂ CG14011KO#2 /+; cav2248/+ 
Progeny   Total  ♀ : ♂  
+/+; cav2248/+  ♀ 77 0.95 : 1 
 ♂ 81 
CG14011KO#2/+; cav2248/+ ♀ 79 1.36 : 1 
  ♂ 58 
+/TM3 & cav2248/TM3 ♀ 141 1.24 : 1 
 ♂ 114 
+/+; TM3/+ & CG14011KO#2/+; TM3/+ ♀ 127 0.96 : 1 
 ♂ 132 
 
Crosses were used to determine the effect of CG14011 interference (CG14011 RNAi) expression 
on sex-specific viability when driven by the A) ubiquitous Act5C-GAL4 driver and B) in a 
CG14011 knock-out allele generated by targeted homologous recombination introduced into 
cav2248 heterozygous fathers crossed to cav2248 heterozygous mothers.  
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Chapter Eight 
Final Discussion 
 
Decreased HOAP levels reduce male viability 
 
The enrichment of testis-specific genes in the set of genes with reduced transcript levels in the 
cav1 mutant expression profiling study led to genetic experiments showing reduced male viability 
in mutants for HOAP.  Preferential lethality was observed with expression of cav interference 
RNA and for two different cav alleles, cav1 and cav2248.  The severity of the male lethal phenotype 
in animals expressing cav interference RNA paralleled the severity of endogenous cav mRNA 
knockdown.  The lethality of both cav1 homogygotes and cav2248 heterozygotes occurred in late 
embryogenesis, as the majority of embryos of these genotypes failing to progress to the larval 
stage were males.  The lethal phase of male cav2248 heterozygotes is late in embryogenesis after 
denticle belt formation, whereas cav2248 homozygotes of both sexes die earlier in embryogenesis 
with a high frequency of telomere fusions.  The dominant male lethal phenotype for cav2248 
heterozygotes is presumably the result of a truncated protein, produced from a nonsense mutation 
within the sequence for the N-terminal HMG-Box, which appears to have dominant negative 
activity.  Its effect on male viability is equivalent to that of knocking down cav mRNA to 20% of 
wild type levels.  The cav1 allele has a frameshift mutation, which results in a C-terminal 
truncation of the protein and severely compromises HP1-binding activity.   Three hypotheses 
were proposed to address the cause of the enhanced male lethality for HOAP mutants: 1) titrating 
effect of Y chromosome on heterochromatin proteins; 2) defect in sex determination and/or 
dosage compensation; 3) defect in male-specific gene expression required for male viability.   
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Presence of heterochromatic Y chromosome is not the cause of reduced male viability 
 
I first tested the hypothesis that the Y chromosome titrates HOAP and other heterochromatin 
proteins away from telomeres and other cell vital regions to make males more vulnerable to 
mutations in these proteins.  The male lethality of mutants for bonus, which encodes the TIF1β 
HP1-interacting protein, is dependent upon the presence of the heterochromatic Y chromosome 
(Beckstead et al., 2005). The introduction of heterochromatin from other chromosomes also 
reduced viability of bonus mutants.  However, in the genetic assay in which a compound X-Y 
chromosome [C(1;Y)] was introduced into animals expressing cav interference RNA, the Y 
chromosome had minimal effect on viability of animals expressing cav RNAi, in comparison to 
the significant effect of the animal’s sex.    
 
Defects in sex determination were observed in cav mutants 
 
Next, I tested the hypothesis that the male lethal phenotype of cav mutants involves defects in the 
sex determination pathway, specifically in Sxl activity.  Sxl, the master regulator of this pathway, 
is normally inactive in males and active in females.  This insures male-specific expression of the 
dosage compensation machinery and appropriate regulation of sexual differentiation genes in 
both sexes.  As an indicator of the function of this pathway in cav mutants, I used RT-PCR assays 
to monitor sex-specific splicing of Sxl transcripts.  The presence of aberrant female Sxl transcripts 
in male cav1 homozygous and cav2248 heterozygous embryos was observed in these assays.  
Genetic assays also indicated that loss of function mutations in Sxl rescue the male lethality of 
cav2248 mutants; however additional crosses with genetic markers that are tightly linked to Sxl are 
still needed to genotype the male progeny.  These assays are underway.  Nevertheless, the genetic 
and RT-PCR assays pointed to a repressive role of HOAP in regulating SXL activity, which was 
then shown through in situ hybridization assays to reflect a role of HOAP in repressing 
transcription from the establishment promoter of the gene (SxlPe).  SxlPe-derived transcripts were 
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inappropriately expressed in male embryos and prematurely expressed in female embryos from 
cav2248 heterozygous parents.   
 
In contrast to the repressive role of HOAP in regulating SxlPe, HP1 appears to have both 
activating and repressing roles on this promoter.  The genetic assay in which female lethality was 
observed in progeny from Su(var)205 mothers and Sxl fathers suggested an activating role for 
HP1 in Sxl expression.  This is consistent with the RT-PCR assays showing male-spliced Sxl 
transcripts in Su(var)205 mutant female larvae, as well as female-spliced transcript in males.  The 
decreased levels of SxlPe-derived transcripts in embryos from Su(var)205 heterozygous parents 
also support a requirement for HP1 in activating SxlPe.  The ChIP assays showed HP1 to be 
associated with the proximal SxlPe region before and during the time of SxlPe activation and HP1 
to be required for stable association of RNAP II with SxlPe in this activation.  ChIP assays also 
showed physical association of HOAP with this proximal region and with two discrete distal 
regions of SxlPe at this time (before and during activation).    
 
Interdependent roles for HOAP and HP1 in SxlPe regulation 
 
Both HP1 and HOAP association with the proximal SxlPe region was reduced in mutants for their 
partner protein.  However, only the reduction in HP1 association in mutants for HOAP was 
considered statistically significant.  This could indicate a greater reliance of HP1 on HOAP for 
binding to SxlPe or reflect the stronger dominant negative activity of the cav2248 mutant allele.  In 
spite of the dependence of HP1 on HOAP, the genetic data also show antagonistic functions of 
the two proteins; introduction of the cav2248 mutation into Su(var)205 mothers completely rescued 
the effect of the Su(var)205 mutation on the viability of female progeny having a reduced zygotic 
dose of Sxl.  A maternal Su(var)205 mutation also rescued the viability of male progeny from 
cav2248 heterozygous fathers.  Taken together, mutants for HP1 and HOAP have antagonistic 
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effects on sex-specific viability and SxlPe activation, yet HP1 is dependent on HOAP for its 
association with SxlPe.      
 
Like HOAP, HP1 may also have a repressive activity at SxlPe.  Knockdown of HP1 by Su(var)205 
interference RNA also causes preferential male lethality (Liu et al., 2005).  The aberrant presence 
of female-spliced Sxl transcripts in male Su(var)205 mutants suggests a requirement for HP1 in 
repressing Sxl expression in males.  A repressive role for HP1 at SxlPe is also consistent with the 
partial rescue of female viability in progeny from Su(var)205 mutant mothers and Sxl mutant 
fathers by introduction of  the cav1 allele into these mothers.  This allele produces a HOAP 
protein that is compromised for HP1-binding (Badugu et al., 2005; Cenci et al., 2003), indicating 
that HOAP repression is partly HP1-dependent. 
 
HP1-independent mechanism of HOAP in regulating SxlPe 
 
The presence of HOAP alone in the SxlPe-distal region indicates an HP1-independent role for it in 
repressing SxlPe from this region.  Estes et al. (Estes et al., 1995) showed 1400 bp upstream of 
SxlPe is required for full expression in females, although sequence to -200 bp is sufficient to 
provide sex-specific expression.  Regulation within the 1400bp region is dependent upon the 
antagonistic activities of maternally-loaded and zygotically-expressed transcription factors 
encoded by X-linked and autosomal signal elements (XSEs and ASEs) that provide a mechanism 
for determining the X to A ratio.  XSEs include a bZIP protein, sisterless-a (sis-a) (Erickson and 
Cline, 1993) and a beta Helix-Loop-Helix (bHLH) factor, Scute (sis-b) (Torres and Sanchez, 
1989) that form heterodimers with maternal bHLH Daughterless protein (Cabrera and Alonso, 
1991), which bind positive (+) E box binding sites in the SxlPe regulatory region (Figure 5.1).  
The bHLH Deadpan protein (Bier et al., 1992; Younger-Shepherd et al., 1992), the only known 
ASE, binds negative (-) E boxes in this region.   
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 The histone deacetylase activity of a maternal Groucho (Paroush et al., 1994) co-repressor 
complex provides a mechanism for decreasing the sensitivity of the SxlPe regulatory region to 
minor spurious fluctuations in the doses of positive and negative bHLH heterodimers to ensure a 
true readout of the X to A ratio.  HOAP and HP1 presumably have similar dampening effects on 
SxlPe activation.  Their activities in the SxlPe-proximal region are presumably both antagonistic 
and cooperative.  HOAP and HP1 may cooperatively repress SxlPe from this region.  However, 
because HOAP alone is associated with the distal SxlPe region, and its association was not 
significantly affected in the Su(var)205 mutant, HOAP activity in this region is presumably HP1-
independent.  HOAP binding in the distal region overlaps a cluster of positive E-box binding 
sites, but it is absent from the negative E-box binding sites in this region.  This suggests that 
HOAP may repress SxlPe from this region through competition with positive E-box proteins, but 
not negative E-box proteins, for binding to this region.  To further address this model in the 
future, ChIP assays can be used to determine whether the association of Scute and Deadpan with 
SxlPe is affected in the cav2248 mutant embryos and vice versa.  These can be combined with 
promoter fusion assays of the distal and proximal regions to further explore the regulatory roles 
of HOAP and HP1 in each region. 
 
Roles for other proteins in SxlPe regulation 
 
In summary, we propose a model in which HOAP and HP1 form a repressive complex in both 
sexes prior to SxlPe activation (Figure 8.1).  The genetic data for Umbrea RNAi knockdown 
suggest that Umbrea may also play a role in this repressive complex. During activation of SxlPe at 
2-3 hr (cycle 12-14), the complex continues to repress in males but switches to activation mode in 
females.  How HP1 switches to activation mode is an open question.  The expression profiles of 
mRNA for HOAP and HP1 in early embryos may provide one mechanism for the switch (Figure 
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8.2).  The abundance of cav mRNA increases sharply just before the activation of SxlPe and then 
plummets.  In contrast, Su(var)205 mRNA levels are low early in embryogenesis but increase 
dramatically at the time of SxlPe activation.  These inverse expression patterns at the time of SxlPe 
activation could affect this switch by altering the ratio of HOAP to HP1 at SxlPe.    
 
The switch to activation mode might also involve other proteins, such as the Epe1-like CG11033 
protein and Chp1-like Umbrea protein.  Epe1 is recruited to heterochromatic loci of S. pombe 
through Swi6 to de-methylate K9 of histone H3 and facilitate transcription of heterochromatic 
repeats (Zofall and Grewal, 2006).  This prompted us to determine if CG11033 is involved in 
HP1 activation at SxlPe.  Expression of RNAi against CG11033, through either the ubiquitous 
Act5C-GAL4 driver or early embryonic nullo-GAL4 driver reduced male viability.  However, no 
effect was observed when nanos-GAL4 was used to drive maternal expression of CG11033 
RNAi, suggesting that the effects on male viability in the other crosses were completely zygotic.  
The nullo promoter is activate early in embryogenesis (Simpson and Wieschaus, 1990), just 
before a peak of CG11033 transcription (Figure 8.2).  Therefore, expression of CG11033 RNAi 
from the nullo-GAL4 drive could potentially affect SxlPe expression.  But the effects of CG11033 
RNAi knockdown on male, rather than female, viability are consistent with a repression, rather 
than activation, role for it at SxlPe.  My ChIP data for di- and tri-MeH3K9 also do not support a 
role for this histone modification in regulating SxlPe in wild type embryos.  Therefore, the effects 
of CG11033 RNAi knockdown are more likely to be indirect, through effects on the pool of HP1 
available to bind SxlPe, for example. 
 
I also tested the role of Umbrea, as a Chp2-like activity, in SxlPe regulation.  Chp2 is an HP1-like  
protein in S. pombe whose dose shifts the equilibrium of S. pombe HP1 (Swi6) activity towards 
repression (Zofall and Grewal, 2006).  Umbrea is an HP1-like protein that contains a 
chromoshadow domain only and interacts with both HOAP and HP1 at telomeres where it is also 
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required to prevent telomere fusions (Joppich et al., 2009).  Expression of Umbrea interference 
RNA from a nanos-GAL4 driver produced an HP1-like phenotype of reducing male viability in a 
wild type genetic background, but produced a female-lethal phenotype in a Sxl mutant 
background.  Therefore, Umbrea may have a role similar to HP1 in the HOAP/HP1 complex at 
SxlPe-proximal region prior to the time of SxlPe activation.  The peak of Umbrea expression 
around the time of SxlPe activation (Figure 8.2) could even be important in switching HP1 from 
repression mode to activation mode by perturbing the HOAP/HP1 interaction.    
 
The ChIP assays at SxlPe do not support an unambiguous role for histone modifications in the 
activity of HOAP/HP1 at SxlPe in wild type animals.  The association of di- and tri- MeK9H3 
with SxlPe does, however, become significantly enriched in embryos from mutants for either 
Su(var)205 or cav heterozygous parents.  This could suggest that the HOAP/HP1 complex is 
required to prevent this histone modification at SxlPe in wild type animals.  It could also result 
from the global spread of these modifications from heterochromatin to euchromatin observed in 
Su(var)205 mutations (Schotta et al., 2002).  Nevertheless, a greater increase was observed at 
SxlPe than at the simultaneously expressed hb promoter, so a parallel role for MeK9H3, and even 
the RNAi machinery, is possible. 
 
Finally, phosphorylation of HP1 could play a role in the switch.  However, the maternal 
expression of transgenes mimicking HP1 phospho-isoforms did not show different levels of 
rescue of the female viability phenotype of Su(var)205 mutant mothers.  This indicates that 
phosphorylation at these PKA sites is not involved in the activity of HP1 at SxlPe or it could 
reflect insufficient promoter activity of the pUAST transgenes used in the germ-line.   There is 
also the possibility that phosphorylation at other sites (e.g. Casein Kinase II) plays a role. 
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HOAP in dosage compensation 
 
The enhanced male lethal phenotype is also observed in mutants for HP1 and SU(VAR)3-7 that 
has been found to involve a defect in the process of dosage compensation (Spierer et al., 2008; 
Spierer et al., 2005) . The DCC is delocalized from the X to the chromocenter in these mutants.  
The zygotic requirement for HOAP in my RNAi knockdown experiments could be related to a 
defect in this process.  On the other hand, de-repression of SxlPe in mutants for HOAP, would 
theoretically reduce expression of the crucial component of the DCC (MSL-2), which is a direct 
downstream target of SXL activity at the level of translation (Kelley et al., 1997) .  Decrease in 
MSL-2 expression reduces binding of DCC on the X chromosome; MSL-2 over-expression 
causes de-localization throughout the genome (Demakova et al., 2003).  MSL-2 immunostaining 
of polytene chromosomes from the cav1 mutant, however, showed a normal distribution of MSL-
2 on the X in some chromosome spreads.  De-repression of SxlPe in cav mutants would also be 
expected to be enhanced by introduction of a mutation in msl-2 and suppressed by MSL-2 over-
expression.  The results of these genetic assays (Table 6.1) were difficult to interpret because 
complete lethality of males, and females to less extent, was observed in the control animals for 
the MSL-2-over-expression experiment.  A weak, but insignificant enhancement was observed in 
the msl-2 mutant experiment.  In summary, the results are inconclusive as to whether mutants for 
HOAP have defects in dosage compensation.  The results of the MSL2-immunostaining 
experiments are also inconclusive.  Therefore, a future experiment will be to use MSL-2 
immunoblotting of individually sexed cav1 mutant larvae.  The male embryos that fail to progress 
to the larval stage would be more likely to display defects in MSL-2 expression, but it is not 
possible to use the PCR-based method of sexing embryos and also examine them by western 
blotting.  
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The direct role of HOAP in regulating testis-specific gene expression 
 
Finally, I tested the third hypothesis that a defect in testis-specific gene expression, in addition to 
SxlPe de-repression, accounts for the enrichment of testis-specific genes in genes with reduced 
transcript levels in the cav1 microarray profiling study.  The magnitude of the reduction in these 
transcript levels may be too large to be completely explained by an under-representation of males 
in cav1 mutant larvae.  RT-PCR assays of some of these testis-specific genes showed them to 
have reduced transcript levels in the cav1 mutant males that were able to survive to the larval 
stage.  This result, along with the reduced size of the male gonad in cav1 mutant larvae, may 
reflect a sex transformation in the gonad of cav1 males.  To address this possibility, I can take 
advantage of sex-specific germline reporters (mgm-l-lacZ and ovo-lacZ) to test the sexual identity 
of the germ cells in cav1 male larvae.  I have constructed the reporter strains needed for a future 
member of the lab to use.  There is also a possibility that HOAP has a direct role in regulating 
testis-specific genes.  The HOAP ChIP on chip data on 3L pericentric heterochromatin showed 
that HOAP is associated with testis-specific genes, including CG32459, which was down-
regulated in RT-PCR assays of sex cav1 larvae (Figure 6.2).  To address the possibility, a β-
galactosidase assay can be applied to promoter fusion assay transgenes for the CG32459 5’-
flanking sequence in mutants for cav.  HOAP ChIP assays can also be used to determine if HOAP 
is physically associated with the regulatory regions of other testis-specific genes that had reduced 
expression in the RT-PCR assays of male cav1 mutants (Figure 6.2).  
 
Evolutionary relevance of HOAP function in regulating Sxl 
 
The sex-specific gene regulatory role of HOAP is of particular interest in terms of its homology 
to the sequence-specific class of HMG boxes found in the mammalian SRY (sex-determining 
region Y) protein (Stros et al., 2007), where it is required for activation of testis-specific genes in 
the testis and repression of those genes in the ovary (Oh and Lau, 2006; Oh et al., 2005).  The 
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repressive activity of SRY in the ovary is HP1-dependent (Peng et al., 2009).  The inductive 
effects of the mammalian gonad on somatic development places SRY high in the hierarchy of the 
sex determination pathway in mammals, similar to the position of HOAP in regulating Sxl in 
Drosophila sex determination.  The dominant negative activity of the cav2248 allele, which 
produces a mutant protein that is truncated within the HMG box of HOAP, suggests a role for the 
HMG box in its repressive activity at SxlPe.  The association of HP1 with SxlPe is also dependent 
on this DNA-binding activity.  Furthermore, the ChIP data showing association of HOAP with 
testis-specific genes could also indicate an activity for it, like SRY, in regulating gene expression 
in the testis.   
   
The role of HOAP and HP1 in sex determination is also paralleled in mating type gene regulation 
in S. pombe.  Swi6, the HP1 homolog, is known to be recruited to the mating type locus and 
telomeres through redundant mechanisms of the RNA-induced initiation of transcriptional gene 
silencing (RITS) complex and DNA-binding activities (Atf1/Pcr1) (Hall et al., 2002; Jia et al., 
2004; Petrie et al., 2005).  SxlPe may similarly be subject to both RNAi-independent and RNAi-
dependent regulatory mechanisms; work in the lab of our collaborator, Jamila Horabin at Florida 
State University, shows defects in its regulation in mutants for the RNAi machinery.  The 
increased levels of di- and tri-MeK9H3 we observed in mutants for HP1 and HOAP could be 
related to this. 
 
In spite of the importance of sexual reproduction for eukaryotes, sex determination pathways are 
poorly conserved (Vallender and Lahn, 2006); SRY proteins are restricted to non-placental 
mammals.  The gene for HOAP was first discovered as a fast evolving gene (Schmid and Tautz, 
1997); its rate of non-synonomous to synonymous substitutions between Drosophila species 
(Schmid et al., 1999) and between D. melanogaster populations (Andolfatto, 2001) is one of the 
highest in the D. melanogaster genome.  The N-terminal part of the protein, containing the HMG, 
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is the most highly conserved domain between various Drosophila species; the central part of the 
protein has undergone the most rapid evolution (Schmid et al., 1999) (Figure 8.3).  It is possible 
that the DNA-binding domain of HOAP has an evolutionary history in testis gene regulation, and 
acquisition of an HP1-binding domain in the central and C-terminal region allowed it to take on 
new activities at telomeres.  A testis-specific regulatory role could also be important for it in 
regulation of telomere-specific transposable elements in the germline. 
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Figure 8.1.  Proposed model for regulatory roles of HOAP and HP1 at Sxl gene before and 
during SxlPe activity.  Before SxlPe activity, HOAP, HP1, and possibly Umbrea, form a 
repressive complex at SxlPe proximal regions.  The dashed line surrounding the Umbrea oval 
conveys the ambiguity of this role.  HOAP also binds to SxlPe distal regions.  During SxlPe 
activity, HP1, and possibly Umbrea, switch to an activator mode to allow association of RNA 
Polymerase II to SxlPe only in females.   
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Figure 8.2.  Developmental expression patterns for cav, Su(var)205, Umbrea and CG11033.  
The Log2 Ratio of expression for each gene, relative to the median level of expression of all 
genes, is shown on the Y axis in relationship to specific 1 to 2 hour intervals throughout 
development indicated along the X axis. 
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Figure 8.3.  Sequence alignment for HOAP (anon fe 1G5 gene product) in four Drosophila 
species.  Sequence alignment of anon fe 1G5 gene product from D. melanogaster, D. simulans, 
D. yakuba and D. pseudoobscura is shown.  Dark shading indicates regions of identity; light 
shading indicates regions of similarity. 
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Chapter Nine 
Materials and Methods 
 
Fly strains and markers 
 
The cav RNAi lines were obtained by germline transformation of the pUAST vector containing 
an inverted repeat of a nearly full length cDNA sequence for the cav-RB transcript.  The cav1 
allele is a loss-of-function allele that has non-sense mutation in the third HP1-interacting domain 
(Cenci et al., 2003).  The cav2248 allele was recovered in a screen of progeny from ethane methyl 
sulfonate (EMS)-mutagenized males which failed to complement the original cav1 allele, and the 
sequence of the allele was determined from PCR products obtained from homozygous cav2248 
embryos identified through their lack of the homologous twi-GAL4, UAS-GFP marked balancer 
chromosome (w1118; DrMio/TM3, P{GAL4-twi.G}2.3, P{UAS-2xEGFP}AH2.3, Sb1 Ser1).  The 
Su(var)2055 is a null allele caused by deletions (Eissenberg et al., 1992).  The Act5C-GAL4 (y1 
w*; P{Act5C-GAL4}25FO1/CyO, y+), nullo-GAL4 (y1 w*; P{nullo-GAL4.G}5.20) and nanos-
GAL4 (y1 w*; P{GAL4-nos.NGT}40) lines are GAL4 drivers described in Flybase (Appendix 1).  
Flies in all crosses were reared under uncrowded conditions on standard cornmeal medium 
enriched with active dry yeast.  Unless otherwise noted, all crosses were done at 25°C; Ore R or 
y1w67c23 were used as the wild type control.  Progeny were counted for 8 days beginning on the 
first day of eclosion.   The Z test was used in statistical analyses of distributions in two 
populations (Sprinthall, 2003).  Description of genes can be found on Flybase 
(http://flybase.org/). 
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RT-PCR analysis  
 
RNA was similarly prepared from pools of male and female cav2248 heterozygous and cav1 
homozygous embryos and from individual Su(var)2054/Su(var)2055 larvae.  The cav2248 
heterozygous embryos were identified from a pool of tightly staged embryos that failed to 
progress to the larval stage and contained intermediate levels of GFP expression from the twi-
GAL4, UAS-GFP-marked TM3Sb balancer chromosome.  The cav1 homozygous embryos were 
similarly identified through their lack of GFP expression from this balancer chromosome.  
Su(var)2054/Su(var)2055 larvae were identified through their lack of GFP expression from the 
Act5C-GAL4-marked CyO balancer chromosome.  The sex of individual cav2248 heterozygous 
and cav1 homozygous embryos was first determined through PCR of the Y-linked kl-2 gene from 
a total nucleic acid extraction from individual embryos.  RNA was then purified using Qiagen 
RNeasy Mini Kit (Cat. No. 74104), followed by DNase I treatment using Qiagen RNase-Free 
DNase Set (Cat. No. 79254) from pools of the nucleic acids extracted from individual male or 
female embryos.  The sex of individual Su(var)2054/Su(var)2055 larvae was first determined 
through the presence or absence of the y+-marker from the paternally derived X chromosome and 
then substantiated through PCR assays of the Y-linked kl-2 gene.  RNA purified from these pools 
was quantified spectrophotometrically.  Semi-quantitative RT-PCR assays were carried out with 
10ng total RNA template per 50 μl reaction through the Qiagen One-Step RT-PCR kit (Cat. No. 
210210).  The sequences of all primers used are shown in Appendix 2.  Primers for the 
Drosophila RpA-70 were used in PCR reactions to determine that all RNA samples were DNA-
free before they were used in RT-PCR as a positive control (Appendix 2).  
 
Chromatin Preparation 
 
A modification of the protocol described in (Alekseyenko et al., 2006) was used to prepare cross-
linked chromatin from embryonic progeny from parents of the following genotypes:  wild type 
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(y1w67c23 or yw),  yw; cav2248/TM3Sb,  yw; Su(var)2055/CyO,  yw females x Sxlf1/Y males, and yw; 
Su(var)2055/CyO females X Sxlf1/Y males.  Embryos from yw parents were collected at the 
following developmental stages: 0.75 to 2.75 hr (labeled 1-3 hr), 2-3 hr, and 4-18 hr.  Embryos 
were collected from yw; Su(var)2055/CyO females crossed to Sxlf1/Y males in parallel to those 
from yw females crossed to Sxlf1/Y males (at 2-3 hr stage).  Embryos from yw; cav2248/TM3Sb and 
from yw; Su(var)2055/CyO parents were also collected in parallel (at 0.75 to 2.75 hr stage).  All 
embryo collections and staging were done at 22oC.  Chromatin was prepared from 6.0 g yw 
embryos homogenized in 6.0 ml homogenization buffer [50 mM Hepes at pH 7.6, 60 mM 
potassium chloride, 0.25 M sucrose, protease inhibitor cocktail (Huang et al., 1998)].  The 
homogenate was clarified by centrifugation at 700 x g for 10 minutes (2000 rpm in SS34) to 
remove particulate cellular debris.  The nuclear supernatant was removed and 1/10 volume of 
10% formaldehyde (freshly prepared from paraformaldehyde) was added.  After incubation with 
rotation for 15 minutes at RT, Glycine was added to final concentration 0.25M to stop the cross-
linking.  The cross-linked chromatin was precipitated by centrifugation at ~2000 x g (5000 rpm in 
SS-34 rotor) for 10 min at 4oC and then washed 3 times in phosphate buffered saline (150 mM 
sodium chloride (NaCl), 10 mM sodium phosphate, pH 7.6) (with centrifugation at 2,000 x g 
(5000 rpm in SS-34) for 10 minutes after each wash and re-suspended in 6.0 ml RIPA buffer (50 
mM Tris-HCl, pH 7.6, 1 mM ethylene diamine tetraacetic acid (EDTA), 0.5 mM ethylene glycol 
tetraacetic acid (EGTA), 140 mM NaCl, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS).  
The nuclear fraction was then sonicated in RIPA buffer for 5 X 4 sec bursts on output setting 5 
and aliquoted to 500 μl per tube.  Glycerol was added to each aliquot to final concentration of 5% 
and all aliquots were quickly froze in liquid nitrogen or EtOH/dry ice bath and stored in -70°C.  
An average length of 500 bp was determined by agarose gel electrophoresis of an ethanol 
precipitate of one aliquot.  A scaled down version of the protocol was carried out with 0.5 g 
mutant embryos in 1.0 ml homogenization buffer.  The homogenate was clarified by 
centrifugation at 700 x g (1,000 rpm in microfuge) before adding 1/10th volume formaldehyde as 
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described above.  The cross-linked chromatin was then pelleted by centrifugation at 6,000 rpm.  
All subsequent wash steps were also done with 6,000 rpm centrifugation. The final volume of the 
scaled down sonnicated chromatin fraction was 1.0 ml; this was aliquoted as 200 μl per tube.   
 
Chromatin Immunoprecipitations 
 
Chromatin immunoprecipitations were performed with 500 μl clarified chromatin (200 μl for 
scaled down version), 20-40 μg antibody [20 μl anti-HOAP(Shareef et al., 2003), 20 μl anti-
HP1(#1803) (Huang et al., 1998), anti-RNA polymerase II antibody (Covance MMS-126R, 
MMS-134, or MMS-129R), anti-di  and tri MeK9 histone H3 (Millipore 05-1249 and 05-1242) or 
non-immune IgG (Santa Cruz Biotech. SC-2027 or SC-2025)] in 2.0 ml (1.5 ml in scaled-down 
version) RIPA buffer at 4 oC overnight with rotation,100 μl anti-rabbit (Sigma A914) or anti-
mouse (Sigma A6531) IgG agarose were then added to each ChIP fraction at 4 oC for 3 hours with 
rotation.  Chromatin/agarose was pelleted by centrifugation at 1000 rpm ( x g) for 3 minutes at 4 
°C in microcentrifuge.  Washes were performed as described in (Alekseyenko et al., 2006).  The 
immunoprecipitated material was eluted from the beads by incubation at 37°C for 1 hr with 
rotation in 500 μL TE (1 mM EDTA, 50 mM Tris, pH 8.0) containing 0.5% sodium dodecyl 
sulfate (SDS) and proteinase K (0.1 mg/ml), followed by the addition of NaCl to 0.3 M and SDS 
to 1% and rotation at 65°C over night.  The samples were then extracted once with 
phenol/chloroform, once with chloroform before ethanol precipitation in the presence of glycogen 
(20μg per 1ml).  The purified ChIP DNA is eluted in 30 μl H2O and input DNA is eluted in 200 
μl H2O.   
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Protocol for quantitative real-time PCR 
 
The iCycler iQ real-time PCR detection system (Bio Rad) was used to quantitate Sxl sequences in 
the precipitated DNA from each ChIP fraction.  The primer pairs shown in Appendix 2 were used 
to amplify fragments spanning the Sxl locus as shown in Figure. 5.1.  RpA-70 was used as the 
normalizing standard in most reactions (sequence of primers in Appendix 2).  PCR amplification 
was performed in duplicate in 50 μL SYBR Green qPCR SuperMix (Bio-Rad Cat. No. 170-
8882).  Dissociation curve analysis was performed at the end of 40 cycles, and quantification was 
carried out by Bio-Rad comparative CT methodology with standard curves constructed for each 
primer pair with a serial dilution of input DNA having PCR efficiencies of 80-120%.   
Enrichment of a given sequence in the ChIP fraction was calculated as ng for ChIP/ ng for input 
for the specific Sxl sequence divided by the same for RpA-70 in the same ChIP reaction.  The ng 
of a sequence in a given sample was determined from a standard curve of a 1:5, 1:10, 1:100, and 
1:2,000 dilution of Input DNA of known concentration.  To calculate enrichmenet ng in 200 l 
ChIP was multiplied by 30, before dividing by the ng in 200 l Input x 200 (to equalize for 
different resuspension volumes for ChIP vs. Input after cross-link reversal of similar volumes 
(200 l). These enrichment values were then compared to enrichment of a normalizing control 
(RpA-70 gene or hb promoter sequence).  Enrichment values were also calculated as % input, 
using the absolute signal for a given ChIP fraction relative to the standard curve with Input DNA 
(without translating to ng DMA).  Enrichment determined by this method was not normalized.  
Conclusions obtained by the two methods were identical in all cases, except for the methylation 
data.  
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Statistical Treatment of ChIP data 
 
For each ChIP reaction, at least two biological replicates were done.  A one sample t-test 
[1 tail, unequal (type 3) variance] was performed to identify sequences that were enriched 
in ChIP fractions above background (i.e., > 1); a student’s t test was used to determine 
significance of differences between two samples of equal variance [2 tails, equal (type 2) 
variance]. 
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Appendices 
 
Appendix 1.  List of fly stocks and markers used in this study. 
 
Common Name Proper Name Stock Number 
twi-GAL4, UAS-GFP 
marked balancer 
w1118; DrMio/TM3, P{GAL4-twi.G}2.3, 
P{UAS-2xEGFP}AH2.3, Sb1 Ser1 
BL-6663 
Act5C-GAL4 y1 w*; P{Act5C-GAL4}25FO1/CyO, y+ BL-4414 
nullo-GAL4 y1 w*; P{nullo-GAL4.G}5.20 BL-26875 
nanos-GAL4 y1 w*; P{GAL4-nos.NGT}40 BL-4442 
Sxlf1 y1 cm1 Sxlf1 v1 f1/FM7a/Dp(1;2;Y)w+ BL-3708 
UAS-CG11033-RNAi CG11033 RNAi (VDRC) on 2nd homoz viable VDRC-109295 
UAS-Umbrea-RNAi CG15636 RNAi (VDRC) /TM3Sb on 3 VDRC-13072 
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Appendix 2:  Results of cav1 microarray study (Log2R > 2.0 or < -2.0).  
 
Affy Tag- 
Drosophila 
Genome 1 
 
log 2 R 
 
p value 
 
 
Gene 
Name 
 
cDNA Library 
Representation 
 
 
Chintapalli 
et al. 
tissue/adult 
enrichment 
Parisi et al. 
testes/ovary 
enrichment 
 
Compiled 
Expression 
Data 
 
Genes with Reduced Transcript Levels  
145319_at -2.08 0.003 phm embryo none N/A embryo 
148103_at -69.61 0.004 dro5 multiple multiple N/A multiple 
141293_at -33.65 0.009 CG9362 multiple multiple N/A multiple 
141440_at -14.13 0.01 b multiple multiple N/A multiple 
153219_at -12.12 0.004 CG7768 multiple multiple N/A multiple 
143559_at -7.91 0.008 ple multiple multiple N/A multiple 
143970_at -7.34 0.002 Clk multiple multiple N/A multiple 
144311_at -6.78 0.006 CG4180 multiple multiple N/A multiple 
142188_at -5.9 0.003 Pif1b multiple multiple N/A multiple 
152004_at -5.52 0.009 eya multiple multiple N/A multiple 
143403_at -5.55 0.006 vg multiple multiple N/A multiple 
149054_at -5.01 0.006 CG9452 rare 
multiple-
low N/A multiple 
155099_at -4.30 0.003 bib multiple multiple N/A multiple 
153488_at -3.45 0.001 heph multiple multiple  N/A multiple 
152034_at -3.34 0.008 CG10139 multiple multiple N/A multiple 
152265_at -3.30 0.008 CG11892 multiple multiple N/A multiple 
150844_at -3.19 0.009 CG12068 multiple 
multiple-
low N/A multiple 
155062_at -3.18 0.01 BEAF-32 multiple multiple N/A multiple 
149779_at -3.12 0.004 CG18549 multiple multiple N/A multiple 
143268_at -3.09 0.01 mnd multiple multiple N/A multiple 
144536_at -3.01 0 Tre1 multiple multiple N/A multiple 
145677_at -3 0.007 CG3117 rare multiple N/A multiple 
154844_at -2.79 0.009 cdc2 multiple multiple N/A multiple 
143464_f_at -2.78 0.008 LysB multiple N/A N/A multiple 
144734_at -2.71 0.002 CG12115 multiple multiple N/A multiple 
153480_at -2.69 0.009 Map60 multiple multiple N/A multiple 
141388_at -2.64 0.009 dap multiple multiple N/A multiple 
150195_at -2.64 0.01 CG5316 multiple multiple N/A multiple 
146874_at -2.47 0.003 CG2063 multiple multiple N/A multiple 
145098_at -2.43 0.007 Lsd-2 multiple multiple N/A multiple 
142578_at -2.28 0.002 pr-set7 multiple multiple N/A multiple 
154656_at -2.15 0.009 Aos1 multiple multiple N/A multiple 
153930_at -2.13 0.008 CG5224 multiple multiple N/A multiple 
153243_at -2.11 0.002 lwr multiple multiple N/A multiple 
151082_at -2.08 0.008 CG33111 multiple multiple testis (6.8x) multiple 
143679_at -2.06 0.005 spn-A multiple 
ovary 
(1.8x) N/A ovary 
149186_at -2.28 0.005 Mkrn1 multiple 
ovary 
(2.3x) N/A ovary 
143834_at -2.26 0.008 CycB3 multiple 
ovary 
(2.3x) N/A ovary 
141239_at -2.22 0.009 ovo rare 
ovary 
(2.9x) ovary ovary 
141337_at -53.44 0.006 CG7906 rare eye (113x) N/A rare 
143465_f_at -11.52 0.006 LysC rare N/A N/A rare 
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145643_at -8.16 0.001 CG31684 rare none  N/A rare 
145734_at -4.84 0.002 CG2816 rare 
multiple-
low N/A rare 
152219_at -22.03 0.006 CG6304  testis (57%) testis (9.9x) testis(29.7x) testis  
148801_at -20.31 0.009 CG7804 testis 
testis 
(14.8x) N/A testis  
149981_at -19.92 0.003 CG4546 testis (46%) 
testis 
(10.0x) testis (10.8x) testis  
145909_at -18.45 0.007 CG11043 testis 
testis 
(10.3x) testis (6.4x) testis  
152703_at -17.93 0.003 CG7848 testis (60%) 
testis 
(12.2x) testis (11.0x) testis  
142968_at -17.84 0.01 CG9279 testis (58%) testis (6.5x) testis (37.2x) testis  
144854_at -17.03 0.001 CG15200 testis 
testis 
(10.4x) testis (23.0x) testis  
142673_at -14.42 0 CG8292 testis 
testis 
(15.3x) testis (16.1x) testis  
150757_at -14.12 0.009 CG5017 testis testis (8.9x) testis (19.3x) testis  
147290_at -13.97 0.01 CG3687 testis 
testis 
(12.5x) testis (9.0x) testis  
152992_at -13.46 0.007 CG10934 testis (50%) 
testis 
(13.9x) N/A testis  
146671_at -13.39 0 CG14589 rare 
testis 
(10.2x) testis (5.1x) testis  
152628_at -12.86 0.004 CG1999 rare 
testis 
(10.4x) testis (16.2x) testis  
142331_i_at -12.63 0.002 CG3875 testis 
testis 
(14.2x) N/A testis  
144514_at -12.32 0.009 TrxT N/A testis (6.3x) testis (19.9x) testis  
150334_at -11.69 0.004 CG31178 testis 
testis 
(10.4x) testis (47.3x) testis  
146743_at -11.67 0.005 CG11125 testis 
testis 
(11.9x) testis (10.8x) testis  
151006_at -11.26 0.006 CG15219 testis (71%) 
testis (3.4 
x) testis (4.5x) testis  
147441_at -11.05 0.001 CG17669 testis 
testis 
(14.4x) testis (5.9x) testis  
148940_at -10.82 0.003 CG13725 testis 
testis 
(10.2x) testis (9.7x) testis  
151765_at -10.43 0.007 CG31624 testis testis (4.4x) testis (34.6x) testis  
146412_at -10.2 0.009 CG7094 testis 
testis 
(13.2x) testis (8.0x) testis  
144885_at -9.74 0.01 CG11697 testis 
testis 
(13.8x) testis (8.3x) testis  
149928_at -9.71 0.01 RpL10Aa testis testis (9.2x) testis (34.7x) testis  
144120_at -9.27 0.002 CkIIbeta2 testis 
testis 
(13.1x) testis (16.0x) testis  
143393_at -9.26 0.01 betaTub85D testis (77%) testis (5.6x) testis (33.5) testis  
146804_at -9.19 0.009 CG18449 testis testis (6.0x) testis (31.2) testis  
146302_at -9.14 0.006 ACXA testis 
testis 
(20.1x) testis (6.9x) testis  
147634_at -9.03 0 Grx-1 testis 
testis 
(14.6x) testis (7.2x) testis  
150197_at -8.76 0.008 CG3517 testis (90%) testis (8.3x) testis (34.0x) testis  
153056_at -8.29 0.009 ssp5 testis (98%) testis (9.7x) testis (58.8x) testis  
146241_at -8.26 0.008 CG14926 testis (79%) testis (4.8x) testis (43.2x) testis  
152333_at -8.17 0.002 sm testis (50%) testis (7.1x) testis (29.6x) testis  
147684_f_at -7.89 0.004 CG3927 testis 
testis 
(13.6x) testis (5.9x) testis  
147518_at -7.56 0.01 CG8517 testis testis (6.8x) testis (22.3x) testis  
151443_at -7.5 0.004 CG13245 testis (71%) testis (5.7x) N/A testis  
144286_at -7.36 0.008 CG4218 testis testis N/A testis  
103 
 
(10.8x) 
151906_at -7.33 0.004 CG5538 testis (73%) testis (8.1x) testis (39.1x) testis  
145981_at -7.1 0.001 CG7196 testis testis (12.9) testis (12.9x) testis  
143686_at -7.06 0.001 Arp53D testis testis (14.2) N/A testis  
143432_at -6.81 0.01 Mst98Cb N/A testis (7.2x) testis (90.5x) testis  
146857_at -6.8 0.001 CG13747 testis 
testis 
(10.1x) testis (4.7x) testis  
146552_at -6.79 0.008 CG33322 testis testis (16.6) N/A testis  
144488_at -6.78 0.009 CG7024 testis testis (9.8x) testis (12.6x) testis  
143434_at -6.74 0.01 Mst84Dd testis testis (4.2x) testis (63.9x) testis  
151334_at -6.71 0.004 CR32658 testis N/A testis (16.2x) testis  
150336_at -6.63 0.003 CG17819 testis (67%) 
testis 
(15.5x) N/A testis  
145709_at -6.4 0.009 CG8840 testis 
testis 
(10.6x) testis (13.0x) testis  
145439_at -6.23 0.009 hydra testis 
testis 
(10.2x) N/A testis 
149662_at -6.22 0.001 CG6629 testis 
testis 
(10.9x) testis (29.9x) testis  
145156_at -6.11 0.006 CG8565 N/A 
testis 
(11.8x) testis (40.2x) testis  
150454_at -6.1 0.005 CG10164 testis 
testis 
(11.0x) N/A testis  
149978_at -6.08 0.006 CG14876 testis 
testis 
(12.8x) N/A testis  
146777_at -6.03 0.001 CG30378 testis 
testis 
(10.8x) N/A testis  
145607_at -5.92 0.005 CG7295 testis 
testis 
(14.3x) testis (8.3x) testis  
141371_at -5.78 0 CG13263 testis testis (8.3x) N/A testis  
152084_at -5.7 0.003 sut4 testis 
testis 
(11.9x) N/A testis  
152092_at -5.4 0.005 CG4323 testis 
testis 
(11.9x) testis (28.0x) testis  
146081_at -5.39 0.003 CG13110 testis 
testis 
(12.1x) testis (11.0x) testis  
153027_at -5.29 0.006 CG4669 testis (88%) testis (7.8x) testis (56.4x) testis  
145978_at -5.23 0.007 CG7211 testis testis (9.4x) N/A testis  
143795_at -5.22 0.001 Ssl testis 
testis 
(11.6x) N/A testis  
152391_at -4.89 0.001 CG1340 testis (78%) 
testis 
(16.4x) N/A testis  
152731_at -4.79 0.009 CG8838 testis testis (8.9x) testis (34.1) testis  
151140_at -4.74 0.005 CG30222  testis 
testis 
(10.6x) testis(12.8x) testis  
146805_at -4.72 0.005 CG2127 testis testis (3.8x) testis (106x) testis  
145464_at -4.62 0.003 CG14579 testis 
testis 
(16.3x) testis (3.0x) testis  
148475_at -4.55 0.008 CG3222  testis 
testis 
(10.9x) testis (23.9x) testis  
151971_at -4.51 0.006 CG11060 testis testis (8.1x) N/A testis 
148765_at -4.33 0.008 CG13471 testis 
testis 
(12.5x) N/A testis  
152645_at -4.32 0.006 CG7742 testis testis (9.7x) testis (21.6x) testis  
144447_at -4.27 0.009 CG13021 testis testis (5.0x) N/A testis  
143274_at -4.27 0.003 Mst87F testis testis (2.6x) testis (49.1x) testis  
151454_at -4.2 0.003 CG12167 testis testis (4.3x) N/A testis  
150449_at -4.2 0 CG10177 testis 
testis 
(17.2x) testis (37.5x) testis  
143725_at -4.06 0.004 Dhc36C testis testis (9.5x) testis (4.1x) testis  
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142792_at -4.04 0.007 CG11386 rare 
testis 
(14.5x) N/A testis  
152890_at -3.72 0.007 CG10126 testis testis (4.5x) N/A testis  
144811_at -3.65 0.003 CG15296 testis 
testis 
(10.8x) testis (6.9x) testis  
150362_at -3.65 0.001 CG13855 testis 
testis 
(11.7x) N/A testis  
147932_at -3.58 0 Ppm1 testis 
testis 
(12.5x) testis (10.0x) testis  
151537_at -3.55 0.008 CG33278 testis 
testis 
(19.1x) N/A testis  
147858_at -3.52 0.003 CG3494 testis 
testis 
(10.2x) testis (18.6x) testis 
146608_at -3.33 0.003 CG10834 rare 
testis 
(17.9x) N/A testis  
150618_at -3.27 0.001 CG17770 testis 
testis 
(12.9x) testis (23.1x) testis  
152716_at -3.24 0.01 CG3492 testis 
testis 
(11.0x) testis (22.5x) testis  
149430_at -3.16 0.008 CG1288 testis N/A testis (33.6x) testis  
145315_at -3.09 0.01 CG15040 rare testis (9.1x) N/A testis  
147667_at -3.01 0.008 CG11291 testis 
testis 
(14.1x) N/A testis  
150038_at -2.72 0.005 CG14909 rare 
testis 
(12.0x) testis (5.7x) testis  
148908_at -2.7 0.009 CG13032 testis 
testis 
(13.0x) N/A testis  
146602_at -2.59 0.004 CG1421 N/A 
testis 
(14.5x) testis (3.6x) testis  
146245_at -2.48 0.004 CG14930 testis 
testis 
(15.1x) N/A testis  
142311_at -2.41 0.005 Ubc84D testis 
testis 
(12.7x) testis (13.8x) testis  
149858_at -2.13 0.006 CG9602 testis testis (9.8x) testis (10.4x) testis  
154179_at -6.01 0.005 CG8478 multiple 
testis, ovary 
(2.8x) N/A testis/ovary 
149176_at -4.32 0.001 E(bx) testis 
testis, ovary 
(2.0x) N/A testis/ovary  
147842_at -2.57 0.004 spag testis 
testis, ovary 
(2.0x) N/A testis/ovary  
153420_at -2.54 0.007 Neos multiple 
testis, ovary 
(2.0x) N/A testis/ovary 
141299_at -2.03 0.009 CG12104 embryo 
testis, ovary 
(3.0x) N/A testis/ovary 
Genes with Elevated Transcript Levels 
151237_at 8.17 0.006 CG13230 none carcass N/A carcass 
142147_at 3.01 0.009 CG9466 multiple 
midgut 
(7.5x) N/A midgut 
141389_at 6.85 0.009 Cht9 ubiq 
midgut 
(20.0x) N/A midgut 
144327_at 8.48 0.002 CG7631 rare 
midgut 
(12.5x) N/A midgut 
147334_at 9.83 0.006 CG5550 rare 
midgut 
(12.5x) N/A midgut 
143695_at 10.25 0.004 pcl rare 
midgut 
(17.5x) N/A midgut 
145842_at 10.32 0.008 CG11149 rare 
midgut 
(20.0x) N/A midgut 
142359_at 15.42 0.004 CG30360 rare 
midgut 
(15.6x) N/A midgut 
147598_at 21.43 0.005 Cht4 rare 
midgut 
(11.5x) N/A midgut 
147498_at 2.09 0 CalpA multiple multiple N/A multiple 
151429_at 2.11 0.001 CG14933 multiple multiple N/A multiple 
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153172_at 2.18 0.008 CG31886 multiple multiple N/A multiple 
152413_at 2.2 0.006 l(2)k05819 multiple multiple N/A multiple 
147171_at 2.31 0.007 CG6337 multiple multiple N/A multiple 
154652_at 2.32 0.006 alpha-Est1 multiple multiple N/A multiple 
149632_at 2.51 0.006 Cyp12e1 multiple multiple N/A multiple 
149722_at 3.07 0.008 CG18547 rare multiple N/A multiple 
144407_at 2.54 0.003 CG8310 rare multiple N/A multiple 
145813_at 2.64 0.008 Cyp28d2 multiple multiple N/A multiple 
141351_at 2.8 0.007 kst multiple multiple N/A multiple 
152848_at 2.85 0.001 CG1698 multiple multiple N/A multiple 
147607_at 3.02 0.007 Glycogenin multiple multiple N/A multiple 
142254_at 3.18 0.007 CG10562 multiple multiple N/A multiple 
154737_at 3.31 0 Ndg multiple multiple N/A multiple 
153087_at 3.57 0.008 CG8654 multiple multiple N/A multiple 
142969_at 3.82 0.005 Cys multiple multiple N/A multiple 
144364_at 4.32 0.01 CG14630 multiple multiple N/A multiple 
152083_at 4.45 0.006 CG15093 multiple multiple N/A multiple 
149937_at 4.55 0.005 CG6912 multiple multiple N/A multiple 
152779_at 6.19 0.004 CG8774 multiple multiple N/A multiple 
149964_at 6.35 0.01 CG14872 rare multiple N/A multiple 
142746_at 6.77 0.003 Men multiple multiple N/A multiple 
145897_at 18.05 0.001 CG42369 multiple multiple N/A multiple 
149889_at 2.05 0.005 CG3259 rare 
multiple-
low N/A rare 
145058_at 2.65 0.004 CG1461 none multiple N/A rare 
153504_at 3.23 0.009 CG33137 none 
multiple-
low N/A rare 
147127_s_at 3.56 0.002 CG13323 rare 
multiple-
low N/A rare 
150252_at 4.27 0 CG4362 rare 
multiple-
low  N/A rare 
154595_at 4.65 0.002 CG7526 rare multiple N/A rare 
147126_i_at 5.63 0.001 CG13323 rare multiple N/A rare 
148709_at 5.88 0.002 CG14105 rare 
multiple-
low N/A rare 
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Appendix 3. Primer sequences used in RT-PCR and real-time PCR for ChIP assays. 
 
PCR frag in Fig. 5.1  Sequence  GadFly Coordinates  
+7101F  CAGCTCGCGATCGGTCATGT  6979712-6979731  
+7101R  CGGCGGAAATGGTGGGAGTG  6979916-6979897  
+1218F  GCCAAAGAGGTATGGGTAGC  6985512-6985531  
+1218R  GTGGTTATCCCCCATATGGC  6985743-6985724  
+138F  CGCTTATCCAGGGTTGCCATACCA  6986594-6986617  
+138R  CGGCACCCCTCTGTCGATCC  6986960-6986941  
-101F  GTCCTGCGGGCCATCGATCT  6986915-6986934  
-101R  CGGGGATCCGCGAAATGCAG  6987117-6987098  
-432F  GCCGAAAGGTGGAACGTGGC  6987225-6987244  
-432R  GTATTGTGCTGGTATTGCTTC  6987469-6987449  
-918F  TTTTGCTAGGATTTCGGGTAG  6987721-6987741  
-918R  CTGTTCTTGGCGTTCGATTAG  6987944-6987924  
-1132F  CTAATCGAACGCCAAGAACAG  6987924-6987944  
-1132R  CTAGGGCTTAGGGCTCACTGG  6988169-6988149  
-1394F  TTCCAGTGAGCCCTAAGCCCTAGCC  6988147-6988171  
-1394R  TAGGCCGCCCCACCCACTTG  6988463-6988444  
-1810F  GCTGGAATGGGGTGGTACGG  6988510-6988529  
-1810R  CCCCAAAAGTTTTGTCCGTGATGGAC  6988940-6988915  
-2224F  GTCCATCACGGACAAAACTTTTGGGG  6988915-6988940  
-2224R  AGAACACACATTCACTCAAGCACTGC  6989362-6989337  
-2647F  GATGCATGTACACATCTGTGC  6989424-6989444  
-2647R  ATATGTTTCGGTTCCGCAATG  6989719-6989699  
-3488F  GAAGCGAACATCTTCCCTTGC  6990249-6990269  
-3488R  CGACCGCCCTACGTCGACGGC  6990558-6990538  
-5094F  ACACGGATTGCATGGGGCACA  6991909-6991929  
-5094R  TGACCGACAACCGCGAAACGTG  6992109-6992088  
-5331F  CACGTTTCGCGGTTGTCGGTCA  6992088-6992109  
-5331R  TGAACGAAATCTAACGGGGCTCAAAAGAC  6992404-6992376  
Sxl RT-PCR:    
SxlP1F  CACCGCTGCCCAGCGACAAT  6979801-6979820  
SxlP2F  TTGCGTTTCGTTGGCGAGGACC  6982643-6982662  
SxlP3R  GAGCGCTGAGCGCCAAAACAATTGA  6985955-6985931  
Control primers:    
RpA-70F  CACCGCCGAGGCTCAAGGAC  4088834-4088853  
RpA-70R  TGCAAGGAGGTGGGCGAGTTG  4089056-4089036  
hbF  GCCTGTCAATGCTGGCGACTTTCG  4523493-4523516  
hbR  GAAAGAGCGAACGCCACGAAGGG  4523867-4523845  
kl-2F  GGTTGCCCAATGTGAGTGAAGCGTC  82313-82337  
kl-2R  TCGCTTAGCTCGCCGCCGTA  82775-82756  
Sxl in situs    
SxlPeF  GTTTCTAAGCAGATCCCG  6986495-6986512  
Sxl PeR  GTTCCACTCGTGACAAGTCC  6986902-6986883  
SxlPmF  GGGCGATGCTTGCATGTTGC  6991059-6991078  
SxlPmR  GCGAAACGTGCACACTGC  6992097-6992080  
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